fibrinogen has been researched along with Stroke in 306 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (1.31) | 18.7374 |
1990's | 4 (1.31) | 18.2507 |
2000's | 141 (46.08) | 29.6817 |
2010's | 114 (37.25) | 24.3611 |
2020's | 43 (14.05) | 2.80 |
Authors | Studies |
---|---|
Lan, Y; Li, G; Miao, J; Pan, C; Qiu, X; Sun, W; Wang, H; Wang, Y; Zhao, X; Zhu, S; Zhu, Z | 1 |
Gao, R; Jia, S; Li, T; Song, Y; Tang, X; Wang, P; Xu, B; Xu, J; Yang, Y; Yuan, D; Yuan, J; Zeng, G; Zhang, C; Zhao, X; Zhu, P | 1 |
Jyoti, D; Kumar, R; Mehta, V; Prabhakar, R; Sharma, CB | 1 |
Cheng, X; Dai, X; Lv, H; Wang, F | 1 |
Harris, S; Hidayat, R; Kurniawan, M; Mesiano, T; Rasyid, A; Riyanto, DL; Wiyarta, E | 1 |
Balestrino, M; Bigliardi, G; Dell'Acqua, ML; Forlivesi, S; Furlanis, G; Gentile, M; Giammello, F; Maffei, S; Malfatto, L; Mancini, R; Manganotti, P; Marietta, M; Meletti, S; Melis, M; Migliaccio, L; Moller, J; Musolino, RF; Naccarato, M; Picchetto, L; Piras, V; Randi, V; Romoli, M; Rosafio, F; Scali, I; Testoni, S; Trenti, T; Vandelli, L; Zini, A | 1 |
Jiang, L; Qu, M; Rong, X; Wang, K; Yang, S | 1 |
Hou, R; Wang, N; Wen, H | 1 |
Etscheid, M; Kanse, SM; Kim, JY; Leergaard, TB; Manna, D | 1 |
Bao, Q; Du, X; Guo, Y; Wu, X; Yang, M; Zhang, J; Zhao, K | 1 |
Chen, Y; Han, X; Xu, D; Ye, C | 1 |
Bing, S; Tang, L; Tang, X; Yang, M | 1 |
Chen, BA; Chen, LK; Chung, CP; Lee, WJ; Peng, LN | 1 |
Ariëns, RAS; Undas, A; Ząbczyk, M | 1 |
Badr, MY; Bahey, MG; Elkholy, AA; Mohamed, EA; Reda, AM; Shoeib, SM | 1 |
Capellades, J; Cuadrado-Godia, E; Fernández-Pérez, I; Giralt-Steinhauer, E; Guisado-Alonso, D; Jiménez-Balado, J; Jiménez-Conde, J; Macias-Gómez, A; Moreira, A; Ois, Á; Rey, L; Rodríguez-Campello, A; Roquer, J; Suárez-Pérez, A | 1 |
Gao, Y; Qu, X; Ren, T; Wang, L; Xu, Y | 1 |
Butenas, S; Malinowski, KP; Paszek, E; Undas, A; Ząbczyk, M | 1 |
Chen, W; Ji, L; Mao, L; Wang, J; Xu, Y | 1 |
Brunskill, SJ; Champaneria, R; Dorée, C; Estcourt, LJ; Geneen, LJ; Gibbs, VN; Novak, A; Palmer, AJ; Raval, P | 1 |
Hui, W; Ruirui, J; Youyou, Z; Zhaoyang, L | 1 |
Bang, OY; Choi, JC; Choi, KH; Chung, JW; Heo, SH; Hwang, YH; Jung, JM; Kim, BJ; Kim, CK; Kim, GM; Kim, JM; Kim, JT; Kim, YJ; Nam, KW; Oh, K; Park, JH; Park, KY; Park, MS; Seo, WK; Song, TJ; Yu, S | 1 |
Xiao, ZX; Zeng, L; Zhang, SD | 1 |
Cervone, M; Di Vincenzo, O; Esposito, A; Morena, A; Natale, R; Pagano, E; Pasanisi, F; Scalfi, L | 1 |
Huang, P; Yi, XY | 1 |
Lou, M; Xu, J; Yan, S; Zhang, R; Zhang, X | 1 |
Chen, H; He, J; He, W; Lin, S; Liu, Y; Zhao, K | 1 |
Adamowicz, J; Dudzik-Płocica, A; Filipiak, KJ; Gorko, D; Kotkowski, M; Legosz, P; Płatek, AE; Ryś, A; Semczuk-Kaczmarek, K; Szymański, FM | 1 |
Harshfield, EL; Markus, HS; Ouwehand, WH; Sims, MC; Traylor, M | 1 |
Baj, Z; Kaczorowska, B; Pawelczyk, M | 1 |
Chen, Y; Li, G; Li, H; Li, S; Liang, Z; Qin, Q; Quan, X; Wang, D; Wei, J; Wei, Y; Yang, Q; Zhou, L | 1 |
Chen, W; Chen, X; Li, S; Ren, B; Wang, Y; Xu, F; Zou, G | 1 |
Cao, Y; Liu, CF; Liu, H; Qin, W; Shi, J; Shi, R; Xu, J; Zhang, X | 1 |
Li, D; Li, Y; Xing, C; Zhu, X | 1 |
Eriksson, H; Heikkilä, HM; Ijäs, P; Koskinen, S; Kovanen, PT; Lindsberg, PJ; Mäyränpää, MI; Nuotio, K; Silvennoinen, H; Soinne, L; Valanne, L; Vikatmaa, P | 1 |
Cruz-Flores, S; Cushman, M; Kamin Mukaz, D; McCullough, LD; Zakai, NA | 1 |
Deneva, T; Peycheva, M; Zahariev, Z | 1 |
Chen, Y; Cheng, H; Cheng, Q; He, J; He, W; Huang, G; Liu, Y; Ruan, Y; Yuan, C; Zeng, Y | 1 |
Cao, L; Huang, X; Zui, FQ | 1 |
Afonso, C; Bonino, L; Borthagaray, G; López, E; Medeiros, R; Pitt, A; Rossi, S; Sousa, B; Spickett, C | 1 |
Cao, L; Huang, X | 1 |
Bagoly, Z; Baráth, B; Bogáti, R; Csiba, L; Katona, É; Orbán-Kálmándi, R; Sarkady, F; Szegedi, I | 1 |
Bikov, A; Meszaros, M; Schwarz, EI | 1 |
Feng, X; Huang, Q; Li, X; Liao, D; Liu, Z; Luo, Y; Tu, R; Wei, M; Xia, J; Ying, Y; Yu, F; Zhang, L; Zhao, T | 1 |
Giannandrea, D; Romoli, M; Zini, A | 1 |
Demchuk, AM; Hong, JM; Kang, DR; Lee, JS; Lee, SE; Lee, SJ; Ovbiagele, B | 1 |
Cui, CJ; Dong, Q; Du, Y; Gao, Y; Guo, YL; Li, JJ; Li, S; Li, XL; Qing, P; Sun, J; Wu, NQ; Xu, RX; Yang, SH; Zhang, Y; Zhu, CG | 1 |
Cao, Y; Du, H; Fan, L; Liu, CF; Liu, H; Ma, Z; Pei, S; Qiu, C; Yin, X; You, S; Zhang, Y; Zhao, H; Zheng, D; Zhong, C | 1 |
Lin, J; Liu, JF; Liu, M; Wei, CC; Yang, TT; Zhang, SH; Zhang, ST | 1 |
Amouyel, P; Arveiler, D; Empana, JP; Evans, A; Ferrieres, J; Gaye, B; Kee, F; Montaye, M; Ruidavets, JB; Tafflet, M; Wagner, A | 1 |
Ma, A; Pan, X; Yang, S; Yin, R | 1 |
Aguilar, E; Altes, P; Álvarez, LR; Esteban, C; García-Díaz, AM; Jiménez, PE; Monreal, M; Perez, P; Sahuquillo, JC; Sánchez Muñoz-Torrero, JF | 1 |
Chen, L; Hu, X; Huang, J; Li, Y; Qiao, S; Wang, J; Wu, J; Xu, S | 1 |
Houng, AK; Reed, GL; Singh, S | 1 |
Branco, JP; Cordeiro, G; Cunha, L; Freire Gonçalves, A; Oliveira, S; Pinheiro, J; Santos Costa, J; Sargento-Freitas, J | 1 |
Liang, J; Lu, T; Weng, B; Xian, W; Yang, H | 1 |
Li, GZ; Liu, D; Liu, LL; Liu, QQ; You, CJ | 1 |
Chen, J; Liu, M; Ren, C; Sun, D; Zhang, S | 1 |
Hu, XP; Qu, LD; Wang, JY; Wang, K; Zhang, GJ; Zhang, H; Zhuo, SX | 1 |
Arnold, N; Beutel, ME; Binder, H; Blankenberg, S; Eggebrecht, L; Göbel, S; Jünger, C; Lackner, KJ; Laubert-Reh, D; Münzel, T; Pfeiffer, N; Prochaska, JH; Schulz, A; Spronk, HM; Ten Cate, H; Wild, PS | 1 |
Goehre, F; Jahromi, BR; Lawton, M; Ludtka, C; Meisel, HJ; Ota, N; Schwan, S; Tanikawa, R; Tews, J | 1 |
Bi, P; Dong, Y; Guo, Y; Jiang, A; Li, X; Luo, H; Zhang, B | 1 |
Bigliardi, G; Dell'acqua, ML; Marietta, M; Nichelli, P; Picchetto, L; Rosafio, F; Trenti, T; Vandelli, L; Varani, M; Zini, A | 1 |
Acharya, P; Billett, HH; Chinnadurai, T; Forest, SJ; Goldstein, DJ; Jakobleff, WA; Jorde, UP; Kizer, JR; Mellas, N; Patel, SR; Saeed, O | 1 |
Kiechl, S; Kirchmayr, M; Knoflach, M; Matosevic, B; Pechlaner, R; Ruecker, M; Werner, P; Willeit, J; Zangerle, A | 1 |
Guo, J; He, G; He, L; Lei, L; Lu, Q; Wang, Y; Xiao, J; Xu, Y; Yin, Y; Yu, L; Zhang, J; Zhao, J | 1 |
Bandinelli, S; Basu, S; Baumert, J; Becker, DM; Becker, LC; Bevan, S; Bis, JC; Boerwinkle, E; Boomsma, DI; Buckley, BM; Campbell, H; Chambers, JC; Chasman, D; Chen, MH; Clarke, R; Cucca, F; Curb, JD; Danesh, J; Davies, G; de Geus, EJ; Deary, IJ; Dehghan, A; Dichgans, M; Eaton, CB; Erdmann, J; Eriksson, JG; Eriksson, P; Ferrucci, L; Folkersen, L; Folsom, AR; Fornage, M; Franco, OH; Franco-Cereceda, A; Franzosi, MG; Gieger, C; Goel, A; Grant, PJ; Green, D; Gross, M; Grotevendt, A; Guo, X; Hamsten, A; Haritunians, T; Harris, SE; Hayward, C; Hofman, A; Homuth, G; Hopewell, JC; Hottenga, JJ; Huang, J; Huffman, JE; Ikram, MA; Illig, T; Jacobs, D; Johnson, AD; Jukema, JW; Kathiresan, S; Kocher, T; Koenig, W; Kolcic, I; Kooner, JS; Lahti, J; Liewald, DC; Liu, S; Lopez, LM; Lowe, GD; Lumley, T; Mälarstig, A; Markus, HS; McArdle, WL; McKnight, B; Mehra, R; Morange, PE; Mosley, TH; Naitza, S; Navarro, P; Nelson, CP; O'Donnell, CJ; Oudot-Mellakh, T; Palotie, A; Peters, A; Polasek, O; Psaty, BM; Pulanic, D; Räikkönen, K; Redline, S; Reilly, MP; Reiner, AP; Ridker, PM; Rivadeneira, F; Rose, LM; Rothwell, PM; Rotter, JI; Rudan, I; Rudnicka, AR; Rumley, A; Sabater-Lleal, M; Saleheen, D; Samani, NJ; Sanna, S; Sattar, N; Schlessinger, D; Schunkert, H; Seedorf, U; Sennblad, B; Seshadri, S; Shin, SY; Silveira, A; Smith, NL; Song, J; Soranzo, N; Spector, TD; Starr, JM; Steri, M; Stott, DJ; Strachan, DP; Strawbridge, RJ; Sudlow, CL; Swords Jenny, N; Tanaka, T; Tang, W; Tarasov, KV; Taylor, KD; Teichert, M; Teumer, A; Tofler, GH; Tracy, RP; Tregouet, D; Trompet, S; Uitterlinden, AG; van Dongen, J; Völzke, H; Wallace, R; Wallaschofski, H; Watkins, H; Widen, E; Wild, SH; Willemsen, G; Williams, FM; Wilson, JF; Witteman, JC; Wright, AF; Yanek, LR; Yao, J; Zemunik, T | 1 |
Chen, S; He, X; Liu, J; Wang, L; Wang, Y; Weng, S; Yang, GY; Zeng, L | 1 |
Chełstowski, K; Clark, J; Jastrzębska, M; Nowacki, P; Siennicka, A; Wódecka, A | 1 |
Grover, A; Kumar, A; Kumar, P; Prasad, K; Sagar, R; Sahu, JK; Srivastava, AK; Vivekanandhan, S | 1 |
Baranov, DA; Gusev, VV; Kuznetsov, NN; Lvova, OA; Partylova, EA; Voroshilina, ES | 1 |
Cao, YJ; Chen, J; Li, RX; Liu, CF; Qian, JF; Wang, JS; Wang, WH; Wu, QY; Xu, Y; You, NX; Yuan, L; Zhai, WQ; Zhang, X; Zhao, Z | 1 |
Chen, N; Feng, H; Guo, J; He, L; Lang, Q; Zhou, M | 1 |
Gu, L; Guo, X; Huang, G; Liang, B; Long, J; Su, L; Tan, J; Wu, G; Yan, Y | 1 |
Gu, L; Huang, G; Liang, B; Liu, W; Su, L; Tan, J; Wu, G; Yan, Y | 1 |
Dziedzic, T; Janowska, A; Klimkowicz-Mrowiec, A; Pera, J; Polczak, A; Slowik, A; Swarowska, M | 1 |
Kopyta, I; Sarecka-Hujar, B; Sordyl, J; Sordyl, R | 1 |
Chang, L; Li, HH; Tao, SB; Yan, HQ; Yuan, B; Zhang, LJ; Zhao, JH | 1 |
Dardiotis, E; Dziedzic, T; Fountas, K; Gąsowski, J; Golenia, A; Hadjigeorgiou, G; Jagiełła, J; Klimkowicz-Mrowiec, A; Paterakis, K; Pera, J; Słowik, A; Wnuk, M | 1 |
Erkinjuntti, T; Karhunen, PJ; Kaste, M; Martiskainen, M; Oksala, A; Oksala, N; Pohjasvaara, T | 1 |
Chasman, DI; Elias, JA; Loscalzo, J; Ridker, PM; Rose, L | 1 |
Bladbjerg, EM; Gram, J; Jespersen, J; Sidelmann, JJ; Skov, J | 1 |
Baj, Z; Chmielewski, H; Kaczorowska, B; Pawelczyk, M; Przybyła, M | 1 |
Bernstein, RA; Conners, JJ; Cutting, S; Lee, VH; Prabhakaran, S; Song, SY | 1 |
Dziedzic, T; Klimkowicz-Mrowiec, A; Pera, J; Polczak, A; Slowik, A; Swarowska, M | 1 |
Djikic, D; Kocev, N; Lip, GY; Marinkovic, JM; Polovina, MM; Potpara, TS | 1 |
Berthezene, Y; Berthiller, J; Cho, TH; Derex, L; Farghali, A; Ffrench, P; Hanss, M; Mechtouff, L; Nighoghossian, N; Ritzenthaler, T; Schott, AM | 1 |
Bigliardi, G; Casoni, F; Cavazzuti, M; Cenci, MA; Gambini, M; Marietta, M; Nichelli, P; Pentore, R; Trenti, T; Vandelli, L; Zini, A | 1 |
Alameda, F; Bosch-Morató, M; Caballo, C; Escolar, G; Galan, AM; Gil-Gómez, G; Guivernau, B; Guix, FX; Ill-Raga, G; Jiménez-Conde, J; Lopez-Vilchez, I; Muñoz, FJ; Ois, A; Opazo, C; Palomer, E; Pérez-Asensio, F; Planas, AM; Ramos-Fernández, E; Reyes-Navarro, M; Roquer, J; Tajes, M; Valls-Comamala, V; Valverde, MA | 1 |
Balcerzyk, A; Emich-Widera, E; Iwanicki, T; Kaciński, M; Kopyta, I; Niemiec, P; Nowak, T; Pienczk-Ręcławowicz, K; Pilarska, E; Sarecka-Hujar, B; Wendorff, J; Zak, I | 1 |
Li, M; Liu, LB; Xu, AD; Zhang, YS; Zhuo, WY | 1 |
Averett, RD; Fan, NK; Keegan, PM; Platt, MO | 1 |
Luo, TY; Zhang, XF | 1 |
Boltes, A; Cocho, D; Espinosa, J; Gendre, J; Jimenez, M; Otermin, P; Pons, J; Ricciardi, AC | 1 |
Brown, MR; D'Silva, L; Davidson, SJ; Evans, PA; Evans, V; Hawkins, K; Lawrence, M; Morris, RH; Potter, JF; Sabra, A; Stanford, SN; Storton, S; Wani, M; Williams, PR | 1 |
Cai, H; Cai, Y; Chen, Z; Qi, H; Tan, L; Wu, G | 1 |
Chen, YF; Liu, YJ; Lu, WH; Luo, CH; Su, BR | 1 |
Cushman, M; Howard, G; Howard, VJ; O'Neal, WT; Safford, MM; Soliman, EZ; Zakai, NA | 1 |
Kassner, A; Merali, Z | 1 |
Chen, WM; Coull, B; Dupuis, J; Dzhivhuho, G; Furie, KL; Gogarten, SM; Hsu, FC; Keene, KL; Lin, H; Madden, EB; Malik, R; Mehndiratta, P; Nelson, S; Rich, SS; Rowles, JL; Sale, MM; Seshadri, S; Southerland, AM; Williams, SR; Worrall, BB | 1 |
Braun, A; Chen, W; Gotru, SK; Haining, EJ; Hermanns, HM; Kraft, P; Lesch, KP; Nieswandt, B; Schuhmann, MK; Stoll, G; Tseng, YL; Wolf, K | 1 |
Gao, M; Liu, Y; Longo, S; McGillis, S; Popescu, M; Wang, D; Zhao, LR | 1 |
Hanania, NA; Lavoie, K; Müllerová, H; Rennard, SI; Tal-Singer, R; Vestbo, J; Wouters, EF; Yohannes, AM | 1 |
Erdem, HB; Eroz, R; Ozdemir, G; Ozel, L; Sahin, I; Tasdemir, S; Tatar, A | 1 |
Bjørnerem, Å; Engstad, T; Frøyshov, HM; Halvorsen, DS | 1 |
Bo, D; Cheng-Chun, L; Hua-Dong, Z; Li-Li, Z; Meng, Z; Qian, G; Qin-Hua, W; Wei, L; Xu, Y; Yan-Jiang, W; Zhi-Hong, Z; Zhi-Qiang, X | 1 |
Buring, JE; Everett, BM; Glynn, RJ; Jiménez, MC; Kotler, G; Lee, IM; Rexrode, KM; Ridker, PM; Sesso, HD | 1 |
Declerck, PJ; Gils, A; Jern, C; Jood, K; Lundberg, L; Nilsson, S; Pedersen, A; Redfors, P | 1 |
Chehaibi, K; Mahdouani, K; Slimane, MN; Trabelsi, I | 1 |
Minić, GA | 1 |
Dziedzic, T; Ferens, A; Pera, J; Slowik, A; Swarowska, M | 1 |
Ganger, P; McCoy, MR; Mutzenbach, JS; Pikija, S; Sellner, J; Trkulja, V | 1 |
Hauer, L; Magdic, J; Mutzenbach, JS; Novak, HF; Pikija, S; Sellner, J; Trkulja, V; Unterkreuter, P; Weymayr, F | 1 |
Andrianova, IA; Khasanova, DR; Litvinov, RI; Peshkova, AD; Tutwiler, V; Weisel, JW | 1 |
Bilecen, S; Brandon Bravo Bruinsma, GJ; de Groot, JA; Kalkman, CJ; Moons, KG; Nierich, AP; Spanjersberg, AJ | 1 |
Font, A; Krupinski, J; Luque, A; Slevin, M; Turu, M | 1 |
Li, J; Liu, L; Sheng, W; Xu, X | 1 |
Cushman, M; Folsom, AR; Longstreth, WT; Rosamond, WD; Shahar, E; Sturgeon, JD | 1 |
Fehér, G; Horváth, B; Komoly, S; Márton, Z; Szapáry, L; Tóth, K | 1 |
Campbell, DJ; Chalmers, J; Lowe, GD; MacMahon, SW; Neal, BC; Rumley, A; Welsh, P; Woodward, M | 1 |
Bos, MJ; Breteler, MM; Cheung, EY; de Maat, MP; Hofman, A; Koudstaal, PJ; Leebeek, FW | 1 |
Cheung, EY; de Lau, LM; de Maat, MP; Dippel, DW; Kluft, C; Laterveer, R; Leebeek, FW; Meijer, P | 1 |
Algra, A; Rosendaal, FR; Siegerink, B | 1 |
Bai, CH; Chen, WH; Chuang, SY; Lien, LM; Pan, WH | 1 |
Di Napoli, M; Singh, P | 1 |
Albers, GW; del Zoppo, GJ; Demaerschalk, BM; Demchuk, AM; Kaste, M; Levy, DE; Pancioli, AM; Ringelstein, EB; Trammel, J; Wasiewski, WW | 1 |
Arnett, DK; Boerwinkle, E; Davis, BR; Eckfeldt, JH; Ford, CE; Leiendecker-Foster, C; Lynch, AI | 1 |
Blauw, GJ; Buckley, BM; Cobbe, S; de Craen, AJ; Ford, I; Jukema, JW; Lowe, GD; Macfarlane, PW; Murphy, MB; Murray, HM; Packard, CJ; Sattar, N; Shepherd, J; Stott, DJ; Welsh, P; Westendorp, RG | 1 |
Carcaillon, L; Dartigues, JF; Ducimetière, P; Gaussem, P; Giroud, M; Ritchie, K; Scarabin, PY | 1 |
Engström, G; Hedblad, B; Li, C | 1 |
Ben-Shlomo, Y; Lowe, GD; Patterson, CC; Rumley, A; Smith, AE; Yarnell, JW | 1 |
Dennis, M; Jackson, C; Lewis, S; Lowe, G; Rumley, A; Sandercock, P; Sudlow, C; Wardlaw, J; Whiteley, W | 2 |
Acemoglu, H; Akcay, F; Can, I; Demir, R; Kuyucu, M; Varoglu, AO | 1 |
Slowik, A; Szczudlik, A; Tracz, W; Undas, A; Wolkow, P | 1 |
Pieculewicz, M; Podolec, P; Stepien, E; Undas, A; Wypasek, E | 1 |
Collins, R; Danesh, J; Di Angelantonio, E; Kaptoge, S; Lowe, G; Pepys, MB; Thompson, SG | 1 |
Carty, CL; Cushman, M; Heagerty, P; Heckbert, SR; Jarvik, GP; Lange, LA; Reiner, AP; Tracy, RP | 1 |
Coplin, WM; Frankel, M; Levine, SR; Lin, Y; Lyden, PD; Rhoney, DH | 1 |
Liu, XF; Ma, MM; Xu, GL; Yang, S; Yue, XY; Zhou, ZM; Zhu, WS | 1 |
Bukowska, H; Chełstowski, K; Honczarenko, K; Jastrzębska, M; Kozłowska-Wojciechowska, M; Makarewicz-Wujec, M; Masztalewicz, M; Mierzecki, A | 1 |
Abdullah, A; Barrocas, AM; Dzik, WH; Goldstein, JN; Marrero, M; Masrur, S; Oleinik, A; Pervez, M; Rosand, J; Schwamm, LH; Smith, EE | 1 |
Emich-Widera, E; Kopyta, I; Marszał, E; Sarecka-Hujar, B; Zak, I | 1 |
Chen, Y; Huang, J; Liu, G; Liu, X; Lu, N; Xu, Y; Yang, D | 1 |
Akyol, A; Kadikoylu, G; Kiylioglu, N; Ozkul, A; Tataroglu, C; Turgut, ET; Yenisey, C | 1 |
Blombäck, M; He, S; Rooth, E; Wallen, NH | 1 |
Alvarez-Perez, FJ; Alvarez-Sabin, J; Castelo-Branco, M | 2 |
Agarwal, SK; Alonso, A; Chamberlain, AM; Folsom, AR; Soliman, EZ; Tang, W | 1 |
Cheung, EY; de Lau, LM; de Maat, MP; den Hertog, HM; Dippel, DW; Koudstaal, PJ; Leebeek, FW; van den Herik, EG | 1 |
Didelez, V; Meng, S; Sheehan, NA | 1 |
Eguchi, K; Hoshide, S; Kario, K; Matsuo, T; Shimada, K; Yano, Y | 1 |
Benbir, G; Ince, B; Kultursay, H; Kumral, E; Ongen, Z; Oto, A; Tokgozoglu, L; Tuzun, H | 1 |
Ding, Y; Ji, X; Li, ZY; Meng, R; Meng, S; Wang, X | 1 |
Masztalewicz, M; Nowacki, P; Safranow, K; Turowska-Kowalska, J | 1 |
Arkhipkin, AA; Karpova, OV; Kochetov, AG; Luk'ianov, AL; Novozhenova, IuV; Ramazanov, GR; Shamalov, NA; Skvortsova, VI | 1 |
Butenas, S; Gissel, M; Mann, KG; Slowik, A; Undas, A | 1 |
Etgen, T; Poppert, H; Sander, D; Sander, K | 1 |
Akassoglou, K; Davalos, D | 1 |
Bembenek, JP; Czlonkowska, A; Karlinski, M; Kobayashi, A | 1 |
Preuss, C; Stoll, M | 1 |
Best, LG; Devereux, RB; Howard, BV; Karas, MG; Kizer, JR; Lee, ET; Roman, MJ; Umans, JG; Whisnant, JP; Wiebers, DO | 1 |
Alexandrov, AV; Barreto, AD | 1 |
Blaes, F; Dziewas, R; Kraus, J; Kunz, AB; Oschmann, P; Reuss, R; Wipfler, P; Young, P | 1 |
Dougu, N; Hirano, K; Kitajima, I; Konishi, H; Nukui, T; Taguchi, Y; Takashima, S; Tanaka, K; Toyoda, S | 1 |
Choi, G; Chung, A; Keller, FS; Lin, YH; Loriaux, MM; Luo, ZH; Nesbit, GM; Pavcnik, D; Rösch, J; Uchida, BT | 1 |
Chegodaev, DA; Kovtun, OP; L'vova, OA | 1 |
Domashenko, MA; Ionova, VG; Maksimova, MIu; Mikhal'chenko, VN; Okhtova, FR; Syskina, EN | 1 |
Eriksson, M; Järemo, P; Lindahl, TL; Milovanovic, M; Nilsson, S | 1 |
Chen, SY; Chiang, YY; Ho, YP; Hsu, HY; Lai, PT; Lee, YS | 1 |
Arkhipkin, AA; Chuĭko, MR; Kochetov, AG; Liang, OV; Novozhenova, IuV; Ogurtsov, PP; Ramazanov, GR; Shamalov, NA; Skvortsova, VI | 1 |
Chen, S; Liu, J; Wang, L; Wang, Y; Weng, S; Yang, GY; Zeng, L | 1 |
Chełstowski, K; Honczarenko, K; Jastrzębska, M; Kozłowska-Wojciechowska, M; Kłoda, K; Mierzecki, A; Naruszewicz, M | 1 |
Anisimov, KV; Arkhipkin, AA; Egorov, VO; Kochetov, AG; Kustova, MA; Liang, OV; Novozhenova, IuV; Podshivalov, DC; Ramazanov, GR; Shamalov, NA | 1 |
Csornai, M; Nagy, Z; Pongrácz, E; Tordai, A | 1 |
Blann, AD; Lip, GY; Ridker, PM | 1 |
Iyigün, I | 1 |
Adler, Y; Behar, S; Boyko, V; Goldbourt, U; Haim, M; Matetzky, S; Mekori, YA; Reshef, T; Tanne, D | 1 |
Anuk, T; Arber, N; Assayag, EB; Avitzour, D; Berliner, S; Bornstein, NM; Fusman, R; Rotstein, R; Shapira, I; Zeltser, D | 1 |
Chełstowski, K; Foltynska, A; Honczarenko, K; Jastrzebska, M; Naruszewicz, M; Torbus-Lisiecka, B | 1 |
Bielański, W; Konturek, PC; Konturek, SJ; Kowalsky, M; Majka, J; Róg, T; Szczudlik, A | 1 |
Catto, AJ; Grant, PJ; Lansbury, AJ | 1 |
Buggle, F; Grau, AJ; Mansmann, U; Marquardt, L; Mayer, H; Ruf, A; Schuler, M; Winter, R | 1 |
Franz, IW; Hopfenmüller, W; Müller, JF; Röcker, L; Tönnesmann, U; Van Der Meyden, J | 1 |
Muir, KW | 1 |
Engström, G; Hedblad, B; Janzon, L; Lind, P; Lindgärde, F; Stavenow, L | 3 |
Chen, JF; Li, CP; Pen, M | 1 |
Erkinjuntti, T; Ilveskoski, E; Karhunen, PJ; Kaste, M; Kunnas, T; Laippala, P; Mäntylä, R; Martiskainen, M; Mikkelsson, J; Pohjasvaara, T | 1 |
Eidelman, RS; Hennekens, CH | 1 |
Ariëns, RA; Carter, AM; Grant, PJ; Lim, BC; Weisel, JW | 1 |
Chu, K; Jeong, SW; Kang, K; Kim, DE; Lee, JW; Roh, JK | 1 |
Lip, GY; Marín, F; Roldán, V | 1 |
Alexy, T; Gaál, V; Horváth, B; Juricskay, I; Késmárky, G; Koltai, K; Márton, Z; Nagy, F; Pálfi, A; Szapáry, L; Szóts, M; Tóth, K | 1 |
Brott, TG; Brown, RD; Crook, RJ; Frankel, M; Hardy, J; Merino, JG; Meschia, JF; Rich, SS; Silliman, S; Worrall, BB | 1 |
Jaeger, BR | 1 |
BUCKELL, M; ELLIOTT, FA | 1 |
BARNHART, MI; GILROY, J; JOHNSON, JF; MEYER, JS | 1 |
FULLERTON, HW; OGSTON, D | 1 |
Jaeger, BR; Labarrere, CA | 1 |
Cangemi, R; Di Lecce, VN; Fimognari, FL; Loffredo, L; Violi, F | 1 |
Berger, D; Demarmels Biasiutti, F; Lämmle, B; Mattle, HP; Wuillemin, WA | 1 |
Chen, S | 1 |
Arakelyan, A; Di Napoli, M | 1 |
Checchia De Ambrosio, C; Cioffi Dagger, RP; Di Rienzo, F; Intiso, D; Lagioia, G; Simone, P; Tonali, P; Zarrelli, MM | 1 |
Grübler, B | 1 |
Audebert, HJ; Haberl, RL; Pellkofer, TS; Wimmer, ML | 1 |
Andrews, PJ | 1 |
Ettinger, MG; Fujishima, H; Kusonoki, R | 1 |
Beevers, GD; Blann, AD; Felmeden, DC; Lip, GY; Martin, SC; Spencer, CG | 1 |
Engström, G; Hedblad, B; Janzon, L; Jonsson, S; Lind, P; Lindgärde, F; Stavenow, L | 1 |
Dong, QL; Zhang, C | 1 |
Parish, JM; Somers, VK | 1 |
Algra, A; Clark, TG; Gutnikov, SA; Howard, SC; Murphy, MF; Power, DA; Rothwell, PM; van Gijn, J; Warlow, CP | 1 |
Brouwers, GJ; Dippel, DW; Gómez-García, EB; Koudstaal, PJ; Leebeek, FW; van Goor, MP | 1 |
Haley, EC; Hemmen, TM; Johnston, KC; Lyden, PD | 1 |
Iso, H | 1 |
Jousilahti, P; Pajunen, P; Rajecki, M; Rasi, V; Salomaa, V; Vahtera, E | 1 |
Bairaktari, ET; Elisaf, MS; Goudevenos, J; Liberopoulos, E; Milionis, HJ; Seferiadis, K | 1 |
Dmoszyńska, A; Grzaśko, N; Soroka-Wojtaszko, M; Słoma-Madej, K | 1 |
Castellanos, M; Castillo, J; Dávalos, A; Gil-Peralta, A; Leira, R; Tejada, J | 1 |
Elisaf, MS; Goudevenos, J; Mikhailidis, DP; Milionis, HJ; Rizos, E; Seferiadis, K | 1 |
Czartoryska, B; Fiszer, U; Krzesiewicz, M; Lechowicz, W; Lugowska, A; Palasik, W | 1 |
Buggle, F; Grau, AJ; Kallenberg, K; Mansmann, U; Marquardt, L; Ruf, A; Winter, R | 1 |
Chambless, LE; Folsom, AR; Nieto, FJ; Wattanakit, K | 1 |
Bhatia, M; Rothwell, PM | 1 |
Campbell, DJ; Chalmers, J; Colman, S; Jenkins, AJ; Kemp, BE; Lowe, GD; MacMahon, SW; Neal, BC; Patel, A; Rumley, A; Woodward, M | 1 |
Bukowska, H; Honczarenko, K; Jastrzebska, M; Mierzecki, A; Millo, B; Torbus-Lisiecka, B | 1 |
Amouyel, P; Arocha-Piñango, CL; Arveiler, D; Assmann, G; Bauer, KA; Ben-Shlomo, Y; Benderly, M; Bingham, A; Brunner, E; Campos, G; Cantin, B; Collins, R; Cooper, JA; Cremer, P; Curb, JD; Cushman, M; D'Agostino, R; Dagenais, GR; Danesh, J; Davey Smith, G; de Maat, MP; De Stavola, B; Després, JP; Dickinson, A; Diez-Ewald, MP; Ducimetiere, P; Elwood, PC; Eriksson, H; Espinosa, R; Evans, AE; Fernandez, V; Ferrieres, J; Feskens, EJ; Folsom, AR; Ford, I; Fowkes, FG; Goldbourt, U; Harald, K; Haverkate, F; Hedblad, B; Ireland, B; Jousilahti, P; Juhan-Vague, I; Juzwishin, K; Kannel, WB; Kaptoge, S; Kiechl, S; Kitamura, A; Knottenbelt, C; Koenig, W; Kostis, JB; Kromhout, D; Lamarche, B; Lappas, G; Lee, AJ; Lewington, S; Lind, P; Loewel, H; Lowe, GD; Marchioli, R; Meade, TW; Memon, A; Mijares, M; Miller, GJ; Nagel, D; Nagy, E; Naito, Y; Nyyssönen, K; Palmieri, V; Palosuo, T; Pekkanen, J; Psaty, BM; Rasi, R; Ridker, P; Robertson, M; Rodeghiero, F; Rodriguez, B; Rodriguez-Larralde, A; Rodriquez-Roa, E; Rosenberg, RD; Rosengren, A; Rudnicka, A; Ryder, E; Salomaa, V; Salonen, JT; Sarwar, N; Sato, S; Schulte, H; Shepherd, J; Shipley, M; Smith, FB; Sweetnam, PM; Thompson, SG; Tofler, G; Torres, E; Tosetto, A; Tracy, RP; Tunstall-Pedoe, H; Tuomainen, TP; Tybjaerg-Hansen, A; Vahtera, E; Valagussa, F; Walker, M; Wheeler, J; White, I; Wilhelmsen, L; Willeit, J; Wilson, AC; Wilson, PW; Wood, A; Woodward, M; Wu, K; Yano, K; Yarnell, JW; Yeh, JL | 1 |
Ben-Shlomo, Y; Lowe, G; Patterson, C; Rumley, A; Smith, A; Yarnell, J | 1 |
Ginsburg, D | 1 |
Engström, G; Hedblad, B; Janzon, L; Lindgärde, F; Rosvall, M | 1 |
Bonura, F; Corrado, E; Muratori, I; Novo, S; Rizzo, M; Tantillo, R; Vitale, G | 1 |
Bella, JN; Best, LG; Devereux, RB; Kizer, JR; Lee, ET; Liu, JE; Palmieri, V; Roman, MJ | 1 |
Gao, X; Yang, H; ZhiPing, T | 1 |
Akdemir, O; Demir, M; Ekuklu, G; Ozbay, G; Turgut, B; Turgut, N; Utku, U; Vural, O | 1 |
Kurl, S; Laaksonen, D; Laukkanen, JA; Niskanen, L; Nyyssönen, K; Salonen, JT; Sivenius, J | 1 |
Brennan, SO; Lowen, R; Matsunaga, A; Mosesson, MW; Siebenlist, KR | 1 |
Ma, AJ; Pan, XD; Xing, Y; Zhang, CS; Zhang, YN | 1 |
Di Napoli, M; Papa, F | 2 |
Adamski, M; Dziedzic, T; Pułyk, R; Strojny, J; Szczudlik, A; Słowik, A; Turaj, W | 1 |
Cai, WW; Chen, XD; Cheng, S; Huang, SX; Liang, L; Liao, XP; Liu, GX; Long, ZG; Sun, C; Tang, XL; Wang, XY; Wen, GQ; Xiao, F | 1 |
Ben Assayag, E; Berliner, S; Bornstein, NM; Bova, I; Rogowski, O; Shapira, I; Shenhar-Tsarfaty, S; Vered, Y | 1 |
Breteler, MM; Conway, DS; Heeringa, J; Hofman, A; Lip, GY; van der Kuip, DA; Witteman, JC | 1 |
Alvarez-Sabín, J; Corral, J; Fernández-Cadenas, I; González-Conejero, R; Iniesta, JA; Marti-Fabregas, J; Montaner, J; Obach, V; Vicente, V | 1 |
Andrikovics, H; Bernát, IS; Csornai, M; Nagy, Z; Pongrácz, E | 1 |
Imano, H; Iso, H; Kitamura, A; Kiyama, M; Naito, Y; Nakamura, M; Noda, H; Ohira, T; Okada, T; Sato, S; Shimamoto, T; Tanigawa, T; Yamagishi, K; Yao, M | 1 |
Meade, TW; Mt-Isa, S; Rudnicka, AR | 1 |
Boden-Albala, B; Coates, K; Elkind, MS; Paik, MC; Sacco, RL; Tai, W | 1 |
Bodanese, LC; Carrion, LJ; Guaragna, JC; Jaeger, CP; Kalil, RA; Petracco, JB | 1 |
Iskra, T; Strojny, J; Szczudlik, A; Słowik, A; Turaj, W; Zwolińska, G | 1 |
Abbate, M; Banfi, C; Bellosta, S; Brioschi, M; Canavesi, M; Gelosa, P; Gianella, A; Guerrini, U; Mussoni, L; Nobili, E; Remuzzi, G; Rottoli, D; Sironi, L; Tremoli, E; Zoja, C | 1 |
Dong, Q; Gu, Y; Han, X; Lin, S; Xue, J; You, H | 1 |
Jakubowski, H; Sikora, M; Twardowski, T | 1 |
Berger, S; Dittrich, R; Dziewas, R; Kraus, J; Kruger, L; Langer, C; Ringelstein, EB; Ritter, M; Schabitz, WR; Young, P | 1 |
Azfar, SF; Beg, M; Gupta, A; Mohammed, J; Nizami, A; Singhal, KC | 1 |
Abou-Saleh, RH; Ajjan, R; Ariëns, RA; Connell, S; Dolling, S; Grant, PJ; Greaves, R; Harrand, R; Lim, BC; Phoenix, F; Smith, DA; Standeven, KF; Weisel, JW | 1 |
Dziedzic, T | 1 |
Borrell, M; Cocho, D; Fontcuberta, J; Martí-Fàbregas, J; Martí-Vilalta, JL; Martínez-Corral, M; Martínez-Ramírez, S | 1 |
Algra, A; Howard, SC; Rothwell, PM | 1 |
Pieters, M; Vorster, HH | 1 |
Krania, E; Kremastinos, DT; Liakos, GK; Panagiotakos, DB; Rallidis, LS; Vikelis, M | 1 |
Gerasimidis, T; Golemati, S; Kadoglou, NP; Kapelouzou, A; Karayannacos, PE; Liapis, CD | 1 |
Ben Assayag, E; Berliner, S; Bornstein, NM; Bova, I; Cohen, M; Shapira, I; Shenhar-Tsarfaty, S; Shopin, L | 1 |
Carlson, CS; Carty, CL; Cushman, M; Durda, JP; Hindorff, LA; Jenny, NS; Jones, D; Lange, LA; Nickerson, D; Reiner, AP; Rice, K; Tracy, RP; Walston, J | 1 |
Blomstrand, C; Danielson, J; Jern, C; Jood, K; Ladenvall, C | 1 |
Nikolova, G; Velcheva, I | 1 |
Chyou, PH; Curb, JD; Kodama, K; Kusumi, S; Rodriguez, BL; Sharp, DS; Shimizu, Y; Tracy, RP; Yano, K | 1 |
Bovill, EG; Cornell, ES; Cushman, M; Feinberg, WM; Hart, RG; Lip, GY; Pearce, LA | 1 |
Bamford, JM; Carter, AM; Catto, AJ; Grant, PJ | 1 |
Crook, MA; Mikhailidis, DP; Wierzbicki, AS; Winder, AF | 1 |
Aloeva, M; Gobejishvili, L; Mantskava, M; Mchedlishvili, G; Momtselidze, N; Shakarishvili, R | 1 |
Atkinson, RP; Chippendale, T; Futrell, N; Hsu, CY; Levin, KA; Levy, DE; Ng, K; Sherman, DG | 1 |
Abumiya, T; Enjyoji, K; Kato, H; Kawai, J; Masuda, J; Ogata, J; Sakata, T; Sasaguri, T; Suzuki, T | 1 |
Badenhorst, CJ; Bourne, LT; Jerling, JC; Jooste, PL; Slazus, W; Steyn, K; Venter, CS; Vorster, HH | 1 |
Mikhailidis, DP; Milionis, HJ; Winder, AF | 1 |
Castillo, J; Chamorro, A; Dávalos, A; Vila, N | 1 |
Baldo-Enzi, G; Calabrò, A; Pessina, AC; Rossi, A; Rossi, GP; Sacchetto, A | 1 |
Balasa, V; Degrauw, A; Fogelson, H; Gartside, P; Glauser, T; Gruppo, R | 1 |
Shamsuzzaman, AS; Somers, VK | 1 |
Konietzko, N; Schreiber, A; Teschler, H; Thilmann, AF; Wang, YM; Wessendorf, TE | 1 |
Bocola, V; Di Napoli, M; Papa, F | 1 |
Fujita, S; Fukamizu, M; Kaizu, K; Nakajima, S; Noguchi, T; Tabuchi, M; Taka, T; Ueda, T; Yamamoto, J | 1 |
Abilleira, S; Alvarez-Sabín, J; Arenillas, J; Codina, A; Molina, C | 1 |
Anders, I; Esterbauer, E; Ladurner, G; Wranek, U | 1 |
Ito, H; Suzuki, T; Takemori, K | 1 |
Al-Saady, NM; Sopher, M | 1 |
Mannucci, PM; Tripodi, A | 1 |
Bang, NU; Biller, J; Bruno, A; Cheryk, LA; Durocher, A; Fleck, JD; McConnell, JP; Meschia, JF; Williams, L | 1 |
Beevers, DG; Lip, GY; Spencer, CG | 1 |
Behar, S; Benderly, M; Boyko, V; Brunner, D; Goldbourt, U; Graff, E; Mandelzweig, L; Reicher-Reiss, H; Shotan, A; Tanne, D | 1 |
Colas, JL; Montalescot, G; Tribouilloy, C | 1 |
Blake, GJ; Lindpaintner, K; Ridker, PM; Schmitz, C | 1 |
Campbell, AM; Lowe, GD; Mansoor, MA; Rumley, A; Spilg, E; Stott, DJ | 1 |
Liu, Y; Pan, J; Wang, S | 1 |
Benetou, V; Bots, ML; Di Carlo, A; Elwood, PC; Freire de Concalves, A; Grobbee, DE; Koudstaal, PJ; Nikitin, Y; Salonen, JT; Sivenius, J; Tuomilehto, J | 1 |
Benetou, V; Bots, ML; Elwood, PC; Freire de Concalves, A; Grobbee, DE; Inzitari, D; Koudstaal, PJ; Moons, KG; Nikitin, Y; Salonen, JT; Sivenius, J; Tuomilehto, J | 1 |
Gutiérrez Martín, M; Iturbe Hernández, T; Moreno Chulilla, JA; Romero Colás, MS | 1 |
Bellini, MA; Boschi, L; Donati, G; Forconi, S; Guerrini, M; Lapi, A; Ricci, D; Trabalzini, L; Turchetti, V | 1 |
Huang, Y; Li, X; Liu, Y; Pan, J; Wang, S | 1 |
Vorster, HH | 1 |
Bamford, J; Bavington, J; Catto, AJ; Grant, PJ; Kain, K; Young, J | 1 |
Bukowska, H; Chelstowski, K; Honczarenko, K; Jastrzebska, M; Naruszewicz, M; Torbus-Lisiecka, B | 1 |
Antovic, J; Bakic, M; Blombäck, M; Ilic, A; Zivkovic, M | 1 |
39 review(s) available for fibrinogen and Stroke
Article | Year |
---|---|
Clinical Significance of Plasma D-Dimer and Fibrinogen in Outcomes after Stroke: A Systematic Review and Meta-Analysis.
Topics: Biomarkers; Clinical Relevance; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostatics; Humans; Stroke | 2023 |
Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice.
Topics: Brain Ischemia; Cardiovascular Diseases; Fibrin; Fibrinogen; Humans; Hypertension; Prospective Studies; Stroke; Thrombosis | 2023 |
Pharmacological interventions for the prevention of bleeding in people undergoing definitive fixation or joint replacement for hip, pelvic and long bone fractures.
Topics: Arthroplasty, Replacement; Fibrinogen; Fractures, Bone; Hemorrhage; Hemostatics; Humans; Myocardial Infarction; Pulmonary Embolism; Stroke; Tranexamic Acid; Transfusion Reaction; Venous Thrombosis | 2023 |
Identifying Genetic and Biological Determinants of Race-Ethnic Disparities in Stroke in the United States.
Topics: Biomarkers; Black or African American; Blood Coagulation; Factor VIII; Fibrin Fibrinogen Degradation Products; Fibrinogen; Genetic Predisposition to Disease; Health Status Disparities; Humans; Incidence; Inflammation; Interleukin-6; Lipoprotein(a); Protein C; Risk Factors; Sickle Cell Trait; Stroke; United States | 2020 |
Successful intravenous thrombolysis for acute ischemic stroke caused by aortic dissection with severe hypofibrinogenemia: a case report and literature review.
Topics: Afibrinogenemia; Aged, 80 and over; Aortic Dissection; Brain Ischemia; Cerebral Hemorrhage; Female; Fibrinogen; Fibrinolytic Agents; Hemiplegia; Humans; Ischemic Stroke; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome | 2022 |
Coagulation and Fibrinolysis in Obstructive Sleep Apnoea.
Topics: Acute Coronary Syndrome; Blood Coagulation Factors; Blood Platelets; Fibrinogen; Fibrinolysis; Gene Expression Regulation; Humans; Hypoxia; Inflammation; Oxidative Stress; Platelet Activation; Platelet Aggregation; Sleep Apnea, Obstructive; Stroke; Venous Thrombosis | 2021 |
Fibrinogen depletion and intracerebral hemorrhage after thrombolysis for ischemic stroke: a meta-analysis.
Topics: Brain Ischemia; Cerebral Hemorrhage; Fibrinogen; Fibrinolytic Agents; Humans; Ischemic Stroke; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome | 2022 |
Biomarkers of cerebral microembolic signals.
Topics: Biomarkers; Brain Ischemia; Chemokine CXCL16; Fibrinogen; Fibrinolytic Agents; Humans; Intracranial Embolism; Neutrophils; Osteoprotegerin; P-Selectin; Plaque, Atherosclerotic; Prognosis; Recurrence; Stroke; T-Lymphocytes, Regulatory | 2017 |
Associations of β-Fibrinogen Polymorphisms with the Risk of Ischemic Stroke: A Meta-analysis.
Topics: Asian People; Brain Ischemia; Case-Control Studies; Fibrinogen; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Phenotype; Polymorphism, Genetic; Risk Factors; Stroke; White People | 2019 |
Multiethnic meta-analysis of genome-wide association studies in >100 000 subjects identifies 23 fibrinogen-associated Loci but no strong evidence of a causal association between circulating fibrinogen and cardiovascular disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Black People; Cardiovascular Diseases; Coronary Artery Disease; Female; Fibrinogen; Genetic Loci; Genetic Predisposition to Disease; Genome-Wide Association Study; Hispanic or Latino; Humans; Male; Middle Aged; Myocardial Infarction; Polymorphism, Single Nucleotide; Risk Factors; Stroke; Venous Thromboembolism; White People; Young Adult | 2013 |
Genetic polymorphism of β-fibrinogen gene-455G/A can contribute to the risk of ischemic stroke.
Topics: Age Factors; Alleles; Asian People; Brain Ischemia; Fibrinogen; Genetic Predisposition to Disease; Humans; Models, Genetic; Odds Ratio; Polymorphism, Genetic; Publication Bias; Risk Factors; Stroke; White People | 2014 |
Influence of the β-fibrinogen-455G/A polymorphism on development of ischemic stroke and coronary heart disease.
Topics: Case-Control Studies; Coronary Artery Disease; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Male; Myocardial Infarction; Polymorphism, Single Nucleotide; Risk Assessment; Stroke | 2014 |
The role of genetic risk factors in arterial ischemic stroke in pediatric and adult patients: a critical review.
Topics: Adult; Blood Coagulation Factors; Blood Vessels; Brain Ischemia; Child; Female; Fibrinogen; Genetic Predisposition to Disease; Hemostasis; Humans; Incidence; Male; Polymorphism, Genetic; Risk Factors; Stroke | 2014 |
FGB gene - 148C>T polymorphism is associated with increased risk of ischemic stroke in a Chinese population: a meta-analysis based on 18 case-control studies.
Topics: Brain Ischemia; Case-Control Studies; China; Fibrinogen; Genetic Markers; Genetic Predisposition to Disease; Humans; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Stroke | 2014 |
Association between the FGB gene polymorphism and ischemic stroke: a meta-analysis.
Topics: Asian People; Case-Control Studies; Fibrinogen; Genetic Markers; Genetic Predisposition to Disease; Humans; Polymorphism, Single Nucleotide; Risk Factors; Stroke | 2015 |
Effect of the -148C/T, 448G/A, and -854G/A Polymorphisms of the β-Fibrinogen Gene on the Risk of Ischemic Stroke in Chinese Population.
Topics: Asian People; Brain Ischemia; Case-Control Studies; China; Fibrinogen; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Odds Ratio; Phenotype; Polymorphism, Genetic; Risk Factors; Stroke | 2015 |
Assessment of Blood-Brain Barrier Disruption in Stroke.
Topics: Albumins; Animals; Blood-Brain Barrier; Brain; Brain Ischemia; Cerebral Hemorrhage; Coloring Agents; Fibrinogen; Fluorescent Antibody Technique; Humans; Immunoglobulin G; Immunoglobulin M; Immunohistochemistry; Magnetic Resonance Imaging; Microscopy, Fluorescence; Microscopy, Fluorescence, Multiphoton; Stroke; Tomography, X-Ray Computed | 2015 |
Angiogenesis and inflammation in carotid atherosclerosis.
Topics: Biomarkers; C-Reactive Protein; Carotid Artery Diseases; Endothelium, Vascular; Fibrin; Fibrinogen; Humans; Inflammation; Neovascularization, Pathologic; Stroke; Tunica Intima | 2008 |
Meta-analysis of genetic studies from journals published in China of ischemic stroke in the Han Chinese population.
Topics: Apolipoproteins E; Asian People; Brain Ischemia; Case-Control Studies; China; Fibrinogen; Genetic Predisposition to Disease; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Odds Ratio; Peptidyl-Dipeptidase A; Periodicals as Topic; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Publication Bias; Risk Assessment; Risk Factors; Stroke | 2008 |
Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6.
Topics: Aged; Aged, 80 and over; Biomarkers; Blood Glucose; C-Reactive Protein; Female; Fibrinogen; Humans; Inflammation; Interleukin-6; Leukocyte Count; Male; Middle Aged; Odds Ratio; Prognosis; Prospective Studies; Stroke | 2009 |
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis.
Topics: Alcohol Drinking; Biomarkers; Blood Pressure; Body Mass Index; C-Reactive Protein; Cholesterol; Coronary Disease; Databases, Factual; Diabetes Mellitus; Female; Fibrinogen; Humans; Interleukin-6; Leukocyte Count; Lung Diseases; Male; Middle Aged; Motor Activity; Neoplasms; Regression Analysis; Risk Assessment; Risk Factors; Serum Albumin; Sex Factors; Smoking; Stroke; Triglycerides | 2010 |
The role of intima-media-thickness, ankle-brachial-index and inflammatory biochemical parameters for stroke risk prediction: a systematic review.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Ankle Brachial Index; C-Reactive Protein; Cytokines; Databases, Bibliographic; Fibrinogen; Humans; Inflammation; Risk Factors; Stroke; Tunica Intima; Tunica Media | 2012 |
Fibrinogen as a key regulator of inflammation in disease.
Topics: Alzheimer Disease; Animals; Arthritis, Rheumatoid; Bacterial Infections; Blood Coagulation; Brain Injuries; Colitis; Fibrinogen; Humans; Inflammation; Kidney Diseases; Multiple Sclerosis; Muscular Dystrophy, Duchenne; Neoplasms; Pulmonary Fibrosis; Spinal Cord Injuries; Stroke; Thrombin; Thromboplastin; Vascular Diseases | 2012 |
Inherited risk factors for thrombotic diseases in children: the genome-wide perspective.
Topics: Adult; Anticoagulants; Child; Drug Resistance; Factor V; Family; Fibrinogen; Genome-Wide Association Study; Humans; Infant, Newborn; Methylenetetrahydrofolate Reductase (NADPH2); Phenotype; Risk Factors; Stroke; Thrombophilia; Venous Thrombosis | 2011 |
Adjunctive and alternative approaches to current reperfusion therapy.
Topics: Aspirin; Electric Stimulation Therapy; Endovascular Procedures; Fibrinogen; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Reperfusion Injury; Stroke; Thrombin; Thrombolytic Therapy; Tomography, X-Ray Computed; Ultrasonic Therapy | 2012 |
Fibrinolytic function and atrial fibrillation.
Topics: Atrial Fibrillation; Cardiovascular Diseases; Disease Susceptibility; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; Insulin Resistance; Matrix Metalloproteinases; Plasminogen; Plasminogen Activator Inhibitor 1; Stroke; Thromboembolism; Tissue Plasminogen Activator | 2003 |
The HELP system for the treatment of atherothrombotic disorders: a review.
Topics: Chemical Precipitation; Coronary Artery Disease; Extracorporeal Circulation; Female; Fibrinogen; Fibrinolytic Agents; Follow-Up Studies; Heparin; Humans; Lipoproteins, LDL; Male; Myocardial Infarction; Plasmapheresis; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Stroke; Treatment Outcome | 2003 |
[Fibrinogen and atherothrombosis: vulnerable plaque or vulnerable patient?].
Topics: Acute Disease; Angioplasty, Balloon, Coronary; Arteriosclerosis; Blood Component Removal; Coronary Restenosis; Female; Fibrinogen; Fibrinolytic Agents; Humans; Hypolipidemic Agents; Male; Meta-Analysis as Topic; Myocardial Infarction; Predictive Value of Tests; Primary Prevention; Prospective Studies; Risk Factors; Stents; Stroke; Syndrome; Thrombosis | 2003 |
Critical care management of acute ischemic stroke.
Topics: Acute Disease; Blood Glucose; Brain Ischemia; Critical Care; Fever; Fibrinogen; Humans; Pneumonia; Respiration, Artificial; Stroke; Thrombolytic Therapy | 2004 |
Obstructive sleep apnea and cardiovascular disease.
Topics: Arousal; Arrhythmias, Cardiac; Arteriosclerosis; C-Reactive Protein; Cardiovascular Diseases; Coronary Disease; Fatigue; Fibrinogen; Heart Failure; Humans; Hypertension; Hypertension, Pulmonary; Interleukin-6; Ischemic Attack, Transient; Oxyhemoglobins; Plasminogen Inactivators; Platelet Aggregation; Polysomnography; Prevalence; Risk Factors; Severity of Illness Index; Sleep Apnea, Obstructive; Stroke | 2004 |
A systematic comparison of the quality and volume of published data available on novel risk factors for stroke versus coronary heart disease.
Topics: Apolipoproteins; C-Reactive Protein; Case-Control Studies; Chlamydophila pneumoniae; Cohort Studies; Coronary Disease; Fibrin Fibrinogen Degradation Products; Fibrinogen; Helicobacter pylori; Humans; Periodicals as Topic; Risk Factors; Stroke | 2005 |
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.
Topics: Adult; Aged; Cause of Death; Coronary Disease; Fibrinogen; Humans; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Risk; Stroke; Vascular Diseases | 2005 |
[The role of homocysteine thiolactone in some of human diseases].
Topics: Animals; Aryldialkylphosphatase; Atherosclerosis; Biomarkers; Fibrinogen; Folic Acid; Homocysteine; Humans; Lipoproteins, HDL; Rabbits; Stroke; Vitamin B 12; Vitamin B 6 | 2006 |
Clinical significance of acute phase reaction in stroke patients.
Topics: Acute Disease; Acute-Phase Reaction; Angiotensin-Converting Enzyme Inhibitors; Animals; Atherosclerosis; C-Reactive Protein; Cerebral Hemorrhage; Fibrinogen; Humans; Inflammation; Interleukin-6; Ischemic Attack, Transient; Stroke; Time Factors; Treatment Outcome | 2008 |
Nutrition and hemostasis: a focus on urbanization in South Africa.
Topics: Black People; Cardiovascular Diseases; Diet; Dietary Fats; Dietary Proteins; Fibrin; Fibrinogen; Hemostasis; Humans; Nutritional Physiological Phenomena; Plasminogen Activator Inhibitor 1; Rural Population; South Africa; Stroke; Urbanization | 2008 |
Lipoprotein (a) and stroke.
Topics: Adult; Aged; Aged, 80 and over; Arteriosclerosis; Cross-Sectional Studies; Female; Fibrinogen; Homocysteine; Humans; Lipids; Lipoprotein(a); Male; Middle Aged; Prospective Studies; Risk Factors; Stroke | 2000 |
Fibrinogen, stroke, and obstructive sleep apnea: an evolving paradigm of cardiovascular risk.
Topics: Cardiovascular Diseases; Female; Fibrinogen; Humans; Male; Risk Factors; Sex Characteristics; Sleep Apnea, Obstructive; Stroke | 2000 |
Laboratory investigation of thrombophilia.
Topics: Activated Protein C Resistance; Antiphospholipid Syndrome; Antithrombins; Clinical Laboratory Techniques; Coronary Thrombosis; Factor V; Factor VIII; Fibrinogen; Humans; Hyperhomocysteinemia; Mutation; Protein C; Protein S; Prothrombin; Stroke; Thrombophilia; Venous Thrombosis | 2001 |
The emergence of cardiovascular disease during urbanisation of Africans.
Topics: Black or African American; Black People; Cardiovascular Diseases; Cholesterol; Diet; Female; Fibrinogen; Health Transition; Humans; Hypertension; Male; Myocardial Ischemia; Risk Factors; Rural Population; Sex Factors; Smoking; South Africa; Stroke; Urban Population; Urbanization | 2002 |
23 trial(s) available for fibrinogen and Stroke
Article | Year |
---|---|
Oral fibrinogen-depleting agent lumbrokinase for secondary ischemic stroke prevention: results from a multicenter, randomized, parallel-group and controlled clinical trial.
Topics: Administration, Oral; Aged; Carotid Intima-Media Thickness; Endopeptidases; Female; Fibrinogen; Humans; Male; Middle Aged; Secondary Prevention; Stroke | 2013 |
Association Between Markers of Inflammation and Total Stroke by Hypertensive Status Among Women.
Topics: Biomarkers; C-Reactive Protein; Cohort Studies; Female; Fibrinogen; Humans; Hypertension; Incidence; Inflammation; Intercellular Adhesion Molecule-1; Middle Aged; Stroke; United States | 2016 |
Effect of Fibrinogen Concentrate on Intraoperative Blood Loss Among Patients With Intraoperative Bleeding During High-Risk Cardiac Surgery: A Randomized Clinical Trial.
Topics: Aged; Aorta; Blood Loss, Surgical; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Coagulants; Double-Blind Method; Elective Surgical Procedures; Female; Fibrinogen; Heart Valve Prosthesis Implantation; Humans; Intraoperative Complications; Ischemic Attack, Transient; Male; Myocardial Infarction; Netherlands; Operative Time; Prospective Studies; Renal Insufficiency; Risk; Sample Size; Stroke | 2017 |
Antihypertensive pharmacogenetic effect of fibrinogen-beta variant -455G>A on cardiovascular disease, end-stage renal disease, and mortality: the GenHAT study.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Chlorthalidone; Coronary Disease; Diuretics; Fibrinogen; Genetic Variation; Genotype; Humans; Hypertension; Kidney Failure, Chronic; Lisinopril; Middle Aged; Stroke; Treatment Outcome | 2009 |
Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events?
Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Biomarkers; C-Reactive Protein; Female; Fibrinogen; Humans; Inflammation; Interleukin-6; Kaplan-Meier Estimate; Male; Myocardial Infarction; Pravastatin; Risk Factors; Stroke | 2009 |
Time of day, outcome, and response to thrombolytic therapy: the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Trial experience.
Topics: Circadian Rhythm; Double-Blind Method; Fibrinogen; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Prospective Studies; Recombinant Proteins; Stroke; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Tomography, X-Ray Computed; Treatment Outcome; United States | 2010 |
[Changes of plasma fibrinogen level among acute ischemic stroke subtypes according to TOAST criteria and effects of Songling Xuemaikang].
Topics: Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Drugs, Chinese Herbal; Female; Fibrinogen; Humans; Male; Middle Aged; Stroke; Treatment Outcome | 2010 |
Usefulness of measurement of fibrinogen, D-dimer, D-dimer/fibrinogen ratio, C reactive protein and erythrocyte sedimentation rate to assess the pathophysiology and mechanism of ischaemic stroke.
Topics: Aged; Biomarkers; Blood Pressure; Blood Sedimentation; Brain Ischemia; C-Reactive Protein; Electrocardiography; Embolism; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Inflammation; Logistic Models; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Socioeconomic Factors; Stroke; Thrombosis | 2011 |
Deep venous thrombosis in acute stroke patients.
Topics: Acute Disease; Aged; Aged, 80 and over; Brain Ischemia; C-Reactive Protein; Female; Fibrinogen; Humans; Male; Middle Aged; Risk Factors; Sex Factors; Stroke; Time Factors; Venous Thrombosis | 2012 |
Is there an effect of folic acid supplementation on the coagulation factors and C-reactive protein concentrations in subjects with atherosclerosis risk factors?
Topics: Adult; Atherosclerosis; Blood Coagulation Factors; C-Reactive Protein; Comorbidity; Dietary Supplements; Dyslipidemias; Female; Fibrinogen; Folic Acid; Humans; Male; Obesity; Risk Factors; Smoking; Stroke; von Willebrand Factor; Young Adult | 2012 |
Course of platelet activation markers after ischemic stroke.
Topics: Aged; Antigens, CD; Biomarkers; Blood Platelets; Brain Ischemia; C-Reactive Protein; Cell Adhesion Molecules; Disease Progression; Female; Fibrinogen; Flow Cytometry; Humans; Leukocyte Count; Male; Middle Aged; Observer Variation; P-Selectin; Platelet Activation; Platelet Membrane Glycoproteins; Reference Values; Risk Factors; Stroke; Tetraspanin 30 | 2002 |
The Ischemic Stroke Genetics Study (ISGS) Protocol.
Topics: Academic Medical Centers; Adult; Brain Ischemia; Case-Control Studies; Cell Line; Clinical Protocols; Female; Fibrinogen; Follow-Up Studies; Gene Expression Profiling; Humans; Male; Platelet Membrane Glycoproteins; Polymorphism, Genetic; Prospective Studies; Reference Values; Sample Size; Stroke; United States | 2003 |
Effects of huo nao fang in 60 cases of ischemic apoplexy.
Topics: Adult; Aged; Blood Viscosity; Drug Combinations; Drugs, Chinese Herbal; Female; Fibrinogen; Humans; Intracranial Thrombosis; Male; Middle Aged; Phytotherapy; Stroke | 2003 |
Hemostatic factors as predictors of stroke and cardiovascular diseases: the FINRISK '92 Hemostasis Study.
Topics: Biomarkers; Cohort Studies; Female; Fibrinogen; Humans; Male; Plasminogen; Risk Factors; Stroke | 2005 |
Associations of inflammatory and hemostatic variables with the risk of recurrent stroke.
Topics: Aged; Brain Ischemia; C-Reactive Protein; Case-Control Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Inflammation; Intracranial Hemorrhages; Ischemic Attack, Transient; Male; Middle Aged; Odds Ratio; Perindopril; Placebos; Recurrence; Risk; Risk Factors; Stroke | 2005 |
Associations of plasma fibrinogen and factor VII clotting activity with coronary heart disease and stroke: prospective cohort study from the screening phase of the Thrombosis Prevention Trial.
Topics: Age Factors; Aged; Coronary Disease; Factor VII; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Risk Factors; Stroke; Thrombosis | 2006 |
Effects of HELP therapy on acute ischemic stroke and vascular endothelial cell function.
Topics: Acute Disease; Aged; Chemical Precipitation; Endothelial Cells; Female; Fibrinogen; Heparin; Humans; Lipoproteins, LDL; Male; Middle Aged; Stroke | 2007 |
Change in hemostatic markers after recombinant tissue-type plasminogen activator is not associated with the chance of recanalization.
Topics: Aged; alpha-2-Antiplasmin; Biomarkers; Brain; Carboxypeptidase B2; Female; Fibrinogen; Fibrinolytic Agents; Humans; Male; Middle Aged; Neovascularization, Physiologic; Predictive Value of Tests; Prospective Studies; Stroke; Time Factors; Tissue Plasminogen Activator; Ultrasonography, Doppler, Transcranial | 2008 |
Intravenous ancrod for treatment of acute ischemic stroke: the STAT study: a randomized controlled trial. Stroke Treatment with Ancrod Trial.
Topics: Ancrod; Brain Ischemia; Double-Blind Method; Female; Fibrinogen; Fibrinolytic Agents; Humans; Infusions, Intravenous; Logistic Models; Male; Middle Aged; Risk; Stroke; Survival Analysis; Time Factors | 2000 |
Proinflammatory cytokines and early neurological worsening in ischemic stroke.
Topics: Aged; Biomarkers; Blood Glucose; Body Temperature; Brain Ischemia; Cohort Studies; Disease Progression; Female; Fibrinogen; Humans; Interleukin-6; Male; Multivariate Analysis; Predictive Value of Tests; Sensitivity and Specificity; Severity of Illness Index; Statistics, Nonparametric; Stroke; Tumor Necrosis Factor-alpha | 2000 |
Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke.
Topics: Aged; Brain Ischemia; C-Reactive Protein; Female; Fibrinogen; Follow-Up Studies; Humans; Logistic Models; Male; Multivariate Analysis; Predictive Value of Tests; Prognosis; Recurrence; Risk Factors; Severity of Illness Index; Stroke; Survival Analysis; Survival Rate | 2001 |
Urinary 11-dehydro-thromboxane B(2) and coagulation activation markers measured within 24 h of human acute ischemic stroke.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Aspirin; Biomarkers; Blood Coagulation; Brain Ischemia; Fibrinogen; Humans; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Stroke; Thromboxane B2 | 2001 |
A prospective study of plasma fibrinogen levels and the risk of stroke among participants in the bezafibrate infarction prevention study.
Topics: Aged; Bezafibrate; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Fibrinogen; Humans; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Prospective Studies; Regression Analysis; Risk; Severity of Illness Index; Stroke; Triglycerides | 2001 |
244 other study(ies) available for fibrinogen and Stroke
Article | Year |
---|---|
Blood biomarkers of post-stroke depression after minor stroke at three months in males and females.
Topics: Biomarkers; Brain-Derived Neurotrophic Factor; Cohort Studies; Depression; Depressive Disorder, Major; Female; Fibrinogen; Humans; Magnesium; Male; Prospective Studies; Stroke | 2022 |
High fibrinogen-to-albumin ratio with type 2 diabetes mellitus is associated with poor prognosis in patients undergoing percutaneous coronary intervention: 5-year findings from a large cohort.
Topics: Albumins; Cohort Studies; Coronary Artery Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Inflammation; Male; Percutaneous Coronary Intervention; Risk Factors; Stroke; Time Factors; Treatment Outcome | 2022 |
Fibrinogen as a Predictor of Early Neurological Deterioration and Poor Outcome in Acute Ischemic Stroke.
Topics: Brain Ischemia; Fibrinogen; Humans; Ischemic Stroke; Retrospective Studies; Risk Factors; Stroke; Treatment Outcome | 2022 |
Risk Factors of Recurrent Stroke in Young and Middle-Aged Stroke Patients after Interventional Therapy.
Topics: Blood Glucose; Cerebral Infarction; Cholesterol; Fibrinogen; Glycated Hemoglobin; Humans; Lipids; Middle Aged; Retrospective Studies; Risk Factors; Stroke | 2022 |
Association of coagulation factors profile with clinical outcome in patient with COVID-19 and acute stroke: A second wave cohort study.
Topics: Adult; Cohort Studies; COVID-19; Fibrinogen; Humans; Prothrombin Time; Retrospective Studies; SARS-CoV-2; Stroke | 2022 |
Fibrinogen Depletion Coagulopathy Predicts Major Bleeding After Thrombolysis for Ischemic Stroke: A Multicenter Study.
Topics: Aged; Blood Coagulation Disorders; Brain Ischemia; Cerebral Hemorrhage; Female; Fibrinogen; Fibrinolytic Agents; Hemostatics; Humans; Ischemic Stroke; Male; Prospective Studies; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome | 2022 |
Risk factors and characteristics of ischemic stroke in patients with immune thrombocytopenia: A retrospective cohort study.
Topics: Adult; Antibodies, Antinuclear; Fibrinogen; Humans; Ischemic Stroke; Purpura, Thrombocytopenic, Idiopathic; Retrospective Studies; Risk Factors; Stroke; Thrombocytopenia | 2022 |
Correlation analysis between D-dimer-to-fibrinogen-ratio and carotid plaque in young patients aged 18-45 with acute cerebral infarction.
Topics: Acute Disease; Adolescent; Adult; Brain Ischemia; Cerebral Infarction; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Middle Aged; Plaque, Atherosclerotic; Stroke; Young Adult | 2022 |
Factor VII activating protease (FSAP) inhibits the outcome of ischemic stroke in mouse models.
Topics: Animals; Coagulants; Disease Models, Animal; Factor VII; Fibrinogen; Fibrinolytic Agents; Histones; Ischemic Stroke; Mice; Peptide Hydrolases; Receptors, Proteinase-Activated; Serine Endopeptidases; Stroke; Tissue Plasminogen Activator | 2022 |
Early myocardial injury and coagulation activation in thoracoscopic left atrial appendage clipping.
Topics: Atrial Appendage; Atrial Fibrillation; Fibrinogen; Humans; Stroke; Treatment Outcome; Troponin I | 2022 |
Association between fibrinogen-to-albumin ratio and hemorrhagic transformation after intravenous thrombolysis in ischemic stroke patients.
Topics: Albumins; Brain Ischemia; Fibrinogen; Humans; Inflammation; Ischemic Stroke; Retrospective Studies; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator | 2023 |
Age- and Sex-Different Associations between Cognitive Performance and Inflammatory Biomarkers in Community Dwelling Older Adults: towards Precision Preventive Strategies.
Topics: Age Factors; Aged; Biomarkers; Cognition; Cross-Sectional Studies; Female; Fibrinogen; Genotype; Humans; Inflammation; Middle Aged; Neuropsychological Tests; Sex Factors; Stroke | 2023 |
Assessment of incidence of cerebral vascular diseases and prediction of stroke risk in chronic obstructive pulmonary disease patients using multimodal biomarkers.
Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Carotid Intima-Media Thickness; Case-Control Studies; Cerebrovascular Disorders; Creatinine; Cross-Sectional Studies; Diffusion Tensor Imaging; Female; Fibrinogen; Humans; Incidence; Interleukin-6; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Quality of Life; Serum Amyloid A Protein; Stroke; von Willebrand Factor | 2023 |
Factors associated with migraine aura mimicking stroke in code stroke.
Topics: Female; Fibrinogen; Humans; Ischemic Stroke; Male; Migraine Disorders; Migraine with Aura; Retrospective Studies; Risk Factors; Stroke | 2023 |
Predictive value of fibrinogen levels for 90-day functional outcomes after intravenous thrombolysis in patients with acute ischaemic stroke.
Topics: Brain Ischemia; Fibrinogen; Fibrinolytic Agents; Humans; Ischemic Stroke; Stroke; Thrombolytic Therapy; Treatment Outcome | 2023 |
Elevated factor XIa as a modulator of plasma fibrin clot properties in coronary artery disease.
Topics: Coronary Artery Disease; Factor XIa; Fibrin; Fibrin Clot Lysis Time; Fibrinogen; Fibrinolysis; Humans; Plasminogen Activator Inhibitor 1; Stroke; Thromboembolism; Thrombosis | 2023 |
Expression of p53, bax and bcl-2 and Predictive Value of Fibrinogen, D-Dimer, and Mean Platelet Volume in Patients with Acute Cerebral Infarction after Intravenous Thrombolysis.
Topics: bcl-2-Associated X Protein; Brain Ischemia; Cerebral Infarction; Fibrinogen; Humans; Mean Platelet Volume; Retrospective Studies; Stroke; Thrombolytic Therapy; Tumor Suppressor Protein p53 | 2022 |
Association between lipoprotein(a) and ischemic stroke: Fibrinogen as a mediator.
Topics: Brain Ischemia; Fibrinogen; Humans; Ischemic Stroke; Lipoprotein(a); Risk Factors; Stroke | 2023 |
D-dimer to fibrinogen ratio predicts early neurological deterioration in ischemic stroke with atrial fibrillation.
Topics: Atrial Fibrillation; Brain Ischemia; Fibrinogen; Humans; Ischemic Stroke; Prospective Studies; Risk Factors; Stroke | 2023 |
Effect of Jin three needles combined with Tong Qiao and blood activation Tang on neurological function, coagulation function and serum level in stroke patients.
Topics: C-Reactive Protein; Cerebral Infarction; Fibrinogen; Humans; Ischemic Stroke; Needles; Retrospective Studies; Stroke; Tumor Necrosis Factor-alpha | 2023 |
High Nutritional Risk Is Associated with Poor Functional Status and Prognostic Biomarkers in Stroke Patients at Admission to a Rehabilitation Unit.
Topics: Aged; Biomarkers; C-Reactive Protein; Female; Fibrinogen; Functional Status; Humans; Male; Malnutrition; Nutrition Assessment; Nutritional Status; Prognosis; Retrospective Studies; Risk Factors; Stroke | 2023 |
Predictive role of admission serum glucose, baseline NIHSS score, and fibrinogen on hemorrhagic transformation after intravenous thrombolysis with alteplase in acute ischemic stroke.
Topics: Blood Glucose; Brain Ischemia; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Ischemic Stroke; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome | 2023 |
Early Fibrinogen Depletion and Symptomatic Intracranial Hemorrhage After Reperfusion Therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fibrinogen; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Male; Middle Aged; Stroke; Thrombectomy; Thrombolytic Therapy; Tissue Plasminogen Activator; Young Adult | 2019 |
High levels of plasma fibrinogen are related to post-stroke cognitive impairment.
Topics: Aged; Blood-Brain Barrier; Brain Ischemia; Case-Control Studies; China; Cognition; Cognitive Dysfunction; Female; Fibrinogen; Humans; Linear Models; Male; Mental Status and Dementia Tests; Middle Aged; Multivariate Analysis; Odds Ratio; Prognosis; Stroke | 2019 |
CHA2DS2-VASc score and fibrinogen concentration in patients with atrial fibrillation.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Catheter Ablation; Female; Fibrinogen; Humans; Male; Middle Aged; Predictive Value of Tests; Risk Assessment; Risk Factors; Stroke; Survival Analysis; Thromboembolism; Time Factors; Treatment Outcome | 2019 |
The role of haematological traits in risk of ischaemic stroke and its subtypes.
Topics: Blood Cell Count; Blood Coagulation; Brain Ischemia; Causality; Factor VIII; Factor XI; Fibrinogen; Fibrinolysis; Genome-Wide Association Study; Humans; Intracranial Embolism; Intracranial Thrombosis; Mendelian Randomization Analysis; Platelet Activation; Risk Factors; Stroke | 2020 |
Fibrinogen concentrations in ischaemic stroke patients with metabolic disorders.
Topics: Brain Ischemia; Cell-Derived Microparticles; Endothelial Cells; Fibrinogen; Humans; Metabolic Diseases; Stroke | 2020 |
Profiling of the Risk Factors and Designing of a Model to Identify Ischemic Stroke in Patients with Non-Hodgkin Lymphoma: A Multicenter Retrospective Study.
Topics: Adult; Aged; Biomarkers; Brain Ischemia; Female; Ferritins; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prothrombin Time; Retrospective Studies; Risk Factors; ROC Curve; Stroke | 2020 |
The Potential Value of D-Dimer to Fibrinogen Ratio in Diagnosis of Acute Ischemic Stroke.
Topics: Aged; Aged, 80 and over; Biomarkers; Brain Ischemia; Case-Control Studies; Diagnosis, Differential; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Predictive Value of Tests; Reproducibility of Results; Stroke | 2020 |
Dynamic Changes in Fibrinogen and Prognosis of Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis.
Topics: Administration, Intravenous; Adult; Aged; Brain Ischemia; Female; Fibrinogen; Fibrinolytic Agents; Humans; Ischemic Stroke; Male; Middle Aged; Prognosis; Registries; Risk Factors; Stroke | 2020 |
Elevated plasma fibrinogen indicates short-term poor outcome in patients with acute ischemic stroke after intravenous thrombolysis.
Topics: Aged; Aged, 80 and over; Biomarkers; Brain Ischemia; Disability Evaluation; Female; Fibrinogen; Fibrinolytic Agents; Humans; Infusions, Intravenous; Male; Middle Aged; Patient Admission; Predictive Value of Tests; Recovery of Function; Registries; Retrospective Studies; Stroke; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Treatment Outcome; Up-Regulation | 2020 |
Predictive Factors for Pre-operative Recurrence of Cerebrovascular Symptoms in Symptomatic Carotid Stenosis.
Topics: Aged; Amaurosis Fugax; Carotid Stenosis; Cross-Sectional Studies; Endarterectomy, Carotid; Female; Fibrinogen; Humans; Hypertension; Ischemic Attack, Transient; Kaplan-Meier Estimate; Lipoproteins, HDL; Lipoproteins, LDL; Longitudinal Studies; Male; Middle Aged; Preoperative Period; Proportional Hazards Models; Prospective Studies; Protective Factors; Recurrence; Risk Factors; Stroke; Time Factors | 2020 |
The role of fibrinogen in acute ischaemic stroke.
Topics: Brain Ischemia; Cerebral Infarction; Fibrinogen; Humans; Ischemic Stroke; Stroke | 2021 |
High fibrinogen-to-albumin ratio is associated with hemorrhagic transformation in acute ischemic stroke patients.
Topics: Albumins; Brain Ischemia; Cerebral Hemorrhage; Fibrinogen; Humans; Intracranial Hemorrhages; Ischemic Stroke; Risk Factors; Stroke | 2021 |
Identification and relative quantification of 3-nitrotyrosine residues in fibrinogen nitrated in vitro and fibrinogen from ischemic stroke patient plasma using LC-MS/MS.
Topics: Brain Ischemia; Chromatography, Liquid; Fibrinogen; Hemostatics; Humans; Ischemic Stroke; Nitrates; Stroke; Tandem Mass Spectrometry; Tyrosine | 2021 |
Rare severe hypofibrinogenemia induced by tissue plasminogen activator in stroke patients: Case report.
Topics: Afibrinogenemia; Aged; Aged, 80 and over; Biomarkers; Female; Fibrinogen; Fibrinolytic Agents; Humans; Male; Rare Diseases; Severity of Illness Index; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator | 2021 |
Incorporation of α2-Plasmin Inhibitor into Fibrin Clots and Its Association with the Clinical Outcome of Acute Ischemic Stroke Patients.
Topics: Antifibrinolytic Agents; Blood Coagulation; Brain Ischemia; Factor XIII; Fibrinogen; Fibrinolysis; Humans; Ischemic Stroke; Stroke | 2021 |
Molecular Biomarkers Associated with Early-Onset Symptomatic Intracranial Atherosclerosis.
Topics: Aged; Apolipoprotein A-I; Apolipoproteins B; Biomarkers; Brain Ischemia; C-Reactive Protein; Case-Control Studies; Fibrinogen; Humans; Intracranial Arteriosclerosis; Male; Middle Aged; Risk Factors; Stroke; Triglycerides | 2021 |
Association of fibrinogen level with early neurological deterioration among acute ischemic stroke patients with diabetes.
Topics: Aged; Brain Ischemia; Cohort Studies; Diabetes Mellitus; Female; Fibrinogen; Humans; Male; Middle Aged; Odds Ratio; Retrospective Studies; Risk Factors; Stroke | 2017 |
Serum fibrinogen and cardiovascular events in Chinese patients with type 2 diabetes and stable coronary artery disease: a prospective observational study.
Topics: Aged; Beijing; C-Reactive Protein; Comorbidity; Coronary Artery Bypass; Coronary Artery Disease; Death; Diabetes Mellitus, Type 2; Female; Fibrinogen; Follow-Up Studies; Glycated Hemoglobin; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Prospective Studies; Stroke; Stroke Volume | 2017 |
Hyperfibrinogenemia is Significantly Associated with an Increased Risk of In-hospital Mortality in Acute Ischemic Stroke Patients.
Topics: Aged; Aged, 80 and over; Brain Ischemia; Female; Fibrinogen; Hospital Mortality; Humans; Male; Middle Aged; Patient Discharge; Proportional Hazards Models; Retrospective Studies; Risk Factors; Severity of Illness Index; Stroke | 2017 |
Association between Fibrinogen and Leukoaraiosis in Patients with Ischemic Stroke and Atrial Fibrillation.
Topics: Aged; Atrial Fibrillation; Brain; Brain Ischemia; Female; Fibrinogen; Humans; Leukoaraiosis; Magnetic Resonance Imaging; Male; Middle Aged; Odds Ratio; Severity of Illness Index; Stroke | 2017 |
Ideal Cardiovascular Health and Incident Cardiovascular Disease: Heterogeneity Across Event Subtypes and Mediating Effect of Blood Biomarkers: The PRIME Study.
Topics: Biomarkers; C-Reactive Protein; Case-Control Studies; Chi-Square Distribution; Coronary Disease; Fibrinogen; Follow-Up Studies; France; Health Status; Hemostasis; Humans; Incidence; Inflammation Mediators; Interleukin-6; Male; Middle Aged; Multivariate Analysis; Northern Ireland; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Factors; Stroke; Time Factors | 2017 |
Raised Fibrinogen Levels and Outcome in Outpatients With Peripheral Artery Disease.
Topics: Aged; Ambulatory Care; Amputation, Surgical; Brain Ischemia; Female; Fibrinogen; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Peripheral Arterial Disease; Registries; Risk Factors; Spain; Stroke | 2018 |
The β-fibrinogen gene 455G/A polymorphism associated with cardioembolic stroke in atrial fibrillation with low CHA
Topics: 5-Lipoxygenase-Activating Proteins; Aged; Atrial Fibrillation; Biomarkers; Case-Control Studies; Cross-Sectional Studies; Female; Fibrinogen; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Intracranial Embolism; Male; Matrix Metalloproteinase 9; Methylenetetrahydrofolate Reductase (NADPH2); Nitric Oxide Synthase Type III; Polymorphism, Single Nucleotide; Risk Assessment; Stroke | 2017 |
Matrix Metalloproteinase-9 Mediates the Deleterious Effects of α2-Antiplasmin on Blood-Brain Barrier Breakdown and Ischemic Brain Injury in Experimental Stroke.
Topics: alpha-2-Antiplasmin; Animals; Blood-Brain Barrier; Brain Ischemia; Capillary Permeability; Cerebral Hemorrhage; Disease Models, Animal; Female; Fibrinogen; Male; Matrix Metalloproteinase 9; Mice, Inbred C57BL; Mice, Knockout; Random Allocation; Single-Blind Method; Stroke | 2018 |
S100β Protein as a Predictor of Poststroke Functional Outcome: A Prospective Study.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Brain Ischemia; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Prognosis; Prospective Studies; Recovery of Function; ROC Curve; S100 Calcium Binding Protein beta Subunit; Severity of Illness Index; Stroke | 2018 |
Early changes in fibrinogen after administration of alteplase are associated with the short-term efficacy of thrombolysis.
Topics: Aged; Aged, 80 and over; Biomarkers; Comorbidity; Female; Fibrinogen; Fibrinolytic Agents; Humans; Logistic Models; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; Stroke; Time Factors; Tissue Plasminogen Activator | 2018 |
Correlation between Fibrinogen and White Matter Hyperintensities among Nondiabetic Individuals with Noncardiogenic Ischemic Stroke.
Topics: Aged; Biomarkers; Brain Ischemia; Chi-Square Distribution; Cross-Sectional Studies; Female; Fibrinogen; Humans; Leukoencephalopathies; Logistic Models; Magnetic Resonance Imaging; Male; Middle Aged; Odds Ratio; Predictive Value of Tests; Preliminary Data; Prospective Studies; Risk Factors; Severity of Illness Index; Stroke; White Matter | 2018 |
Defibrinogen Therapy for Acute Ischemic Stroke: 1332 Consecutive Cases.
Topics: Aged; Aged, 80 and over; Blood Coagulation; Brain Ischemia; Dose-Response Relationship, Drug; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Retrospective Studies; Risk; Safety; Stroke; Treatment Outcome | 2018 |
D-dimer >2.785 μg/ml and multiple infarcts ≥3 vascular territories are two characteristics of identifying cancer-associated ischemic stroke patients.
Topics: Aged; Biomarkers; Brain; Brain Ischemia; Diffusion Magnetic Resonance Imaging; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Neoplasms; Retrospective Studies; Stroke | 2018 |
Intake of Vitamin K Antagonists and Worsening of Cardiac and Vascular Disease: Results From the Population-Based Gutenberg Health Study.
Topics: Adrenomedullin; Adult; Aged; Ankle Brachial Index; Anticoagulants; Asymptomatic Diseases; Atrial Fibrillation; Atrial Natriuretic Factor; C-Reactive Protein; Cardiovascular Diseases; Carotid Intima-Media Thickness; Female; Fibrinogen; Germany; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Phenprocoumon; Protein Precursors; Pulmonary Embolism; Risk Factors; Stroke; Stroke Volume; Vascular Stiffness; Venous Thrombosis; Warfarin | 2018 |
TachoSil Dural Reconstruction in Extracranial-Intracranial Bypass Surgeries.
Topics: Brain Ischemia; Cerebral Revascularization; Cerebrospinal Fluid Leak; Drug Combinations; Dura Mater; Fibrinogen; Humans; Middle Cerebral Artery; Plastic Surgery Procedures; Postoperative Complications; Stroke; Temporal Arteries; Thrombin | 2019 |
Fibrinogen concentrate replacement in ischemic stroke patients after recombinant tissue plasminogen activator treatment.
Topics: Administration, Intravenous; Brain Ischemia; Fibrinogen; Fibrinolytic Agents; Humans; Stroke; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Treatment Outcome | 2019 |
Fibrinogen Albumin Ratio and Ischemic Stroke During Venoarterial Extracorporeal Membrane Oxygenation.
Topics: Adult; Aged; Brain Ischemia; Extracorporeal Membrane Oxygenation; Female; Fibrinogen; Humans; Male; Middle Aged; Retrospective Studies; Serum Albumin; Stroke | 2020 |
Fibrinogen degradation coagulopathy and bleeding complications after stroke thrombolysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Coagulation Disorders; Female; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Prospective Studies; Risk; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator; Young Adult | 2013 |
Association between two functional fibrinogen-related polymorphisms and ischemic stroke: a case-control study.
Topics: Aged; Asian People; Brain Ischemia; Case-Control Studies; Female; Fibrinogen; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Stroke | 2013 |
Differences of circulating inflammatory markers between large- and small vessel disease in patients with acute ischemic stroke.
Topics: Aged; Biomarkers; C-Reactive Protein; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Inflammation; Male; Middle Aged; Stroke | 2013 |
Factors influencing multiplate whole blood impedance platelet aggregometry measurements, during aspirin treatment in acute ischemic stroke: a pilot study.
Topics: Adult; Aged; Aspirin; Blood Platelets; Brain Ischemia; C-Reactive Protein; Cholesterol, HDL; Clopidogrel; Electric Impedance; Female; Fibrinogen; Glycated Hemoglobin; Humans; Leukocyte Count; Leukocytes; Male; Middle Aged; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Stroke; Thromboxane B2; Ticlopidine; von Willebrand Factor | 2013 |
Identification of genetic contribution to ischemic stroke by screening of single nucleotide polymorphisms in stroke patients by using a case control study design.
Topics: Apolipoproteins E; Brain Ischemia; Case-Control Studies; Cyclic Nucleotide Phosphodiesterases, Type 4; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 4; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Nitric Oxide Synthase Type III; Outcome Assessment, Health Care; Polymorphism, Single Nucleotide; Stroke | 2013 |
[The inherited procoagulant and prothrombotic condition as the main etiological factor for ischemic stroke in infants].
Topics: Brain Ischemia; Child, Preschool; Female; Fibrinogen; Fibrinolysis; Humans; Infant; Integrin alpha2; Male; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Single Nucleotide; Stroke; Thrombophilia | 2013 |
Research on the relationship between fibrinogen level and subtypes of the TOAST criteria in the acute ischemic stroke.
Topics: Aged; Brain Ischemia; Female; Fibrinogen; Humans; Male; Multivariate Analysis; Retrospective Studies; Stroke | 2013 |
The sustained increase of plasma fibrinogen during ischemic stroke predicts worse outcome independently of baseline fibrinogen level.
Topics: Aged; Brain Infarction; Brain Ischemia; Female; Fibrinogen; Humans; Male; Middle Aged; Multivariate Analysis; Prognosis; Prospective Studies; Regression Analysis; Retrospective Studies; Risk Factors; Stroke; Time Factors; Treatment Outcome | 2014 |
The FGA Thr312Ala polymorphism and risk of intracerebral haemorrhage in Polish and Greek populations.
Topics: Aged; Cerebral Hemorrhage; Female; Fibrinogen; Genes, Dominant; Genetic Predisposition to Disease; Genotype; Greece; Humans; Male; Middle Aged; Poland; Polymorphism, Genetic; Regression Analysis; Risk; Stroke | 2014 |
Βeta-fibrinogen gene promoter A -455 allele associated with poor longterm survival among 55-71 years old Caucasian women in Finnish stroke cohort.
Topics: Aged; Aged, 80 and over; Alleles; Cohort Studies; Female; Fibrinogen; Finland; Genetic Predisposition to Disease; Genotype; Humans; Middle Aged; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Stroke | 2014 |
Plasma levels of the proinflammatory chitin-binding glycoprotein YKL-40, variation in the chitinase 3-like 1 gene (CHI3L1), and incident cardiovascular events.
Topics: Adipokines; Aged; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Chitinase-3-Like Protein 1; Cholesterol, LDL; Female; Fibrinogen; Genome-Wide Association Study; Humans; Incidence; Intercellular Adhesion Molecule-1; Lectins; Middle Aged; Myocardial Infarction; Polymorphism, Single Nucleotide; Prospective Studies; Stroke | 2014 |
Lysability of fibrin clots is a potential new determinant of stroke risk in atrial fibrillation.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Comorbidity; Cross-Sectional Studies; Female; Fibrin; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Risk Factors; Stroke; Thrombin | 2014 |
Platelet Reactivity in Patients With Stroke and Hyperlipidemia, GPIbα Assessment.
Topics: Aged; Aged, 80 and over; Blood Platelets; Brain Ischemia; Female; Fibrinogen; Follow-Up Studies; Gene Expression Regulation; Humans; Hyperlipidemias; Integrin beta3; Male; Middle Aged; Platelet Activation; Platelet Glycoprotein GPIb-IX Complex; Stroke; Thrombin | 2016 |
Elevated international normalized ratio as a manifestation of post-thrombolytic coagulopathy in acute ischemic stroke.
Topics: Aged; Aged, 80 and over; Blood Coagulation Factors; Cerebral Hemorrhage; Early Diagnosis; Female; Fibrinogen; Fibrinolytic Agents; Humans; International Normalized Ratio; Male; Middle Aged; Retrospective Studies; Risk Factors; Stroke; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator | 2014 |
Hyperfibrinogenemia predicts long-term risk of death after ischemic stroke.
Topics: Biomarkers; Brain Ischemia; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Mortality; Predictive Value of Tests; Prospective Studies; Retrospective Studies; Risk Factors; Stroke; Time Factors | 2014 |
The association of CHA2DS2-VASc score and blood biomarkers with ischemic stroke outcomes: the Belgrade stroke study.
Topics: Aged; C-Reactive Protein; Female; Fibrinogen; Humans; Ischemia; Male; Middle Aged; Prognosis; Risk Factors; Stroke; Treatment Outcome; Troponin I; United States | 2014 |
Fibrinogen and von Willebrand factor and susceptibility vessel sign on T2*-weighted gradient echo imaging.
Topics: Aged; Biomarkers; Brain Ischemia; Cerebral Angiography; Female; Fibrin; Fibrinogen; Humans; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Multivariate Analysis; Severity of Illness Index; Stroke; Thrombolytic Therapy; Treatment Outcome; von Willebrand Factor | 2014 |
Fibrinogen decrease after intravenous thrombolysis in ischemic stroke patients is a risk factor for intracerebral hemorrhage.
Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Cerebral Hemorrhage; Female; Fibrinogen; Fibrinolytic Agents; Humans; Male; Middle Aged; Risk Factors; Stroke; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Treatment Outcome; Young Adult | 2015 |
Fibrinogen nitrotyrosination after ischemic stroke impairs thrombolysis and promotes neuronal death.
Topics: Adult; Aged; Aged, 80 and over; Animals; Apoptosis; Brain; Brain Ischemia; Caspase 3; Cell Line, Tumor; Enzyme Activation; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Neurons; Rats; Rats, Sprague-Dawley; Stroke; Tyrosine | 2015 |
Fibrinogen alpha and beta gene polymorphisms in pediatric stroke--case-control and family based study.
Topics: Adolescent; Alleles; Case-Control Studies; Child; Female; Fibrinogen; Genotype; Humans; Male; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Stroke | 2015 |
The role of hs-CRP, D-dimer and fibrinogen in differentiating etiological subtypes of ischemic stroke.
Topics: Aged; Biomarkers; Brain Ischemia; C-Reactive Protein; Diagnosis, Differential; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Retrospective Studies; ROC Curve; Stroke | 2015 |
Experimental and imaging techniques for examining fibrin clot structures in normal and diseased states.
Topics: Anemia, Sickle Cell; Blood Chemical Analysis; Factor XIIIa; Fibrin; Fibrinogen; Fibrinolysis; Humans; Microscopy, Confocal; Myocardial Infarction; Myocardial Ischemia; Stroke; Thrombin; Thrombosis | 2015 |
Predictors of occult cancer in acute ischemic stroke patients.
Topics: Aged; Aged, 80 and over; Biomarkers; Brain Ischemia; C-Reactive Protein; Female; Fibrinogen; Humans; Male; Middle Aged; Neoplasms; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Severity of Illness Index; Stroke | 2015 |
The changes in clot microstructure in patients with ischaemic stroke and the effects of therapeutic intervention: a prospective observational study.
Topics: Aged; Aged, 80 and over; Aspirin; Case-Control Studies; Cohort Studies; Elasticity; Female; Fibrinogen; Fibrinolytic Agents; Fractals; Humans; Male; Middle Aged; Prospective Studies; Stroke; Thrombosis; Tissue Plasminogen Activator; Whole Blood Coagulation Time | 2015 |
Distinct non-cerebrovascular risk factors for ischemic lacunar stroke and non-lacunar stroke: preliminary results.
Topics: Aged; Alcohol Drinking; Blood Glucose; Brain Ischemia; Case-Control Studies; Diabetes Complications; Dyslipidemias; Fasting; Female; Fibrinogen; Glycated Hemoglobin; Humans; Hypertension; Logistic Models; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Risk Factors; Sex Factors; Smoking; Stroke; Stroke, Lacunar | 2015 |
Inflammation and hemostasis in atrial fibrillation and coronary heart disease: The REasons for Geographic And Racial Differences in Stroke study.
Topics: Aged; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Coronary Disease; Ethnicity; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Geography; Hemostasis; Humans; Inflammation; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk Factors; Stroke | 2015 |
Shared genetic susceptibility of vascular-related biomarkers with ischemic and recurrent stroke.
Topics: Aged; Biomarkers; Brain Ischemia; C-Reactive Protein; Female; Fibrinogen; Gene Expression; Genetic Loci; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Male; Middle Aged; Oxidoreductases; Polymorphism, Single Nucleotide; Randomized Controlled Trials as Topic; Recurrence; Stroke | 2016 |
Partially Defective Store Operated Calcium Entry and Hem(ITAM) Signaling in Platelets of Serotonin Transporter Deficient Mice.
Topics: Animals; Blood Platelets; Calcium; Disease Models, Animal; Fibrinogen; Hemostasis; Hydroxyindoleacetic Acid; Melatonin; Mice; Mice, Knockout; Phosphoric Monoester Hydrolases; Serotonin; Serotonin Plasma Membrane Transport Proteins; Signal Transduction; Stroke; Thrombosis | 2016 |
Fibrinogen Reduction and Motor Function Improvement by Hematopoietic Growth Factor Treatment in Chronic Stroke in Aged Mice: A Treatment Frequency Study.
Topics: Aging; Animals; Chronic Disease; Disease Models, Animal; Fibrinogen; Granulocyte Colony-Stimulating Factor; Mice; Motor Activity; Stem Cell Factor; Stroke | 2016 |
Long-term Course of Depression Trajectories in Patients With COPD: A 3-Year Follow-up Analysis of the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints Cohort.
Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Chemokines, CC; Cohort Studies; Depression; Depressive Disorder; Disease Progression; Dyspnea; Exercise Test; Fatigue; Female; Fibrinogen; Humans; Logistic Models; Longitudinal Studies; Male; Middle Aged; Odds Ratio; Pulmonary Disease, Chronic Obstructive; Pulmonary Surfactant-Associated Protein D; Sex Factors; Stroke; Uteroglobin | 2016 |
Correlation with Platelet Parameters and Genetic Markers of Thrombophilia Panel (Factor II g.20210G>A, Factor V Leiden, MTHFR (C677T, A1298C), PAI-1, β-Fibrinogen, Factor XIIIA (V34L), Glycoprotein IIIa (L33P)) in Ischemic Strokes.
Topics: Blood Coagulation Factors; Blood Platelets; Brain Ischemia; Factor V; Factor XIIIa; Fibrinogen; Genetic Markers; Genetic Predisposition to Disease; Humans; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Prothrombin; Retrospective Studies; Risk Factors; Stroke; Thrombophilia | 2016 |
Elevated inflammatory markers predict mortality in long-term ischemic stroke-survivors: a population-based prospective study.
Topics: Age Factors; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Case-Control Studies; Comorbidity; Female; Fibrinogen; Follow-Up Studies; Humans; Inflammation; Interleukin-6; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk Factors; Stroke; Survivors | 2017 |
Predictive Factors for the Spontaneous Recanalization of Large and Middle Cerebral Arteries after Acute Occlusion.
Topics: Aged; Brain Ischemia; Carotid Arteries; Endovascular Procedures; Erythrocyte Count; Female; Fibrinogen; Humans; Magnetic Resonance Angiography; Male; Middle Aged; Middle Cerebral Artery; Platelet Count; Predictive Value of Tests; Prognosis; Regression Analysis; Retrospective Studies; Stroke; Tissue Plasminogen Activator; Tomography, X-Ray Computed; Treatment Outcome | 2016 |
Haemostatic biomarkers are associated with long-term recurrent vascular events after ischaemic stroke.
Topics: Aged; Biomarkers; Carboxypeptidase B2; Cardiovascular Diseases; Female; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Prognosis; Prospective Studies; Recurrence; Stroke; Tissue Plasminogen Activator; von Willebrand Factor | 2016 |
Correlation of Oxidative Stress Parameters and Inflammatory Markers in Ischemic Stroke Patients.
Topics: Aged; Biomarkers; Blood Glucose; Brain Ischemia; C-Reactive Protein; Diabetes Mellitus, Type 2; Erythrocytes; Female; Fibrinogen; Glutathione Peroxidase; Glycated Hemoglobin; Humans; Inflammation Mediators; Lipids; Male; Middle Aged; Oxidative Stress; Predictive Value of Tests; Prognosis; Stroke; Superoxide Dismutase | 2016 |
Leucocyte count indicates carotid plaque instability in stroke patients.
Topics: Aged; Blood Sedimentation; C-Reactive Protein; Carotid Stenosis; Female; Fibrinogen; Humans; Inflammation; Leukocyte Count; Leukocytes; Male; Middle Aged; Plaque, Atherosclerotic; Stroke; Tomography, X-Ray Computed; Ultrasonography | 2016 |
Can Prediction of Functional Outcome after Stroke Be Improved by Adding Fibrinogen to Prognostic Model?
Topics: Age Factors; Aged; Aged, 80 and over; Biomarkers; Brain Ischemia; Disability Evaluation; Discriminant Analysis; Female; Fibrinogen; Health Status; Health Status Indicators; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Recovery of Function; Retrospective Studies; Risk Factors; Severity of Illness Index; Stroke; Time Factors | 2016 |
Fibrinogen consumption is related to intracranial clot burden in acute ischemic stroke: a retrospective hyperdense artery study.
Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Female; Fibrinogen; Hospital Mortality; Humans; Intracranial Thrombosis; Male; Middle Aged; Multivariate Analysis; Patient Admission; Retrospective Studies; Stroke; Treatment Outcome; Young Adult | 2016 |
Intracranial Thrombus Morphology and Composition Undergoes Time-Dependent Changes in Acute Ischemic Stroke: A CT Densitometry Study.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Brain Ischemia; Female; Fibrinogen; Humans; Intracranial Thrombosis; Male; Middle Aged; Middle Cerebral Artery; Neuroimaging; Retrospective Studies; Severity of Illness Index; Stroke; Tomography, X-Ray Computed | 2016 |
Contraction of Blood Clots Is Impaired in Acute Ischemic Stroke.
Topics: Adult; Aged; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Brain Ischemia; Case-Control Studies; Cerebrovascular Circulation; Female; Fibrinogen; Humans; Intracranial Thrombosis; Kinetics; Male; Middle Aged; Platelet Activation; Severity of Illness Index; Stroke | 2017 |
Hemostatic and inflammatory risk factors for intracerebral hemorrhage in a pooled cohort.
Topics: Age Distribution; Aged; Biomarkers; C-Reactive Protein; Cerebral Hemorrhage; Cohort Studies; Factor VIII; Female; Fibrinogen; Follow-Up Studies; Humans; Leukocyte Count; Lipoprotein(a); Male; Middle Aged; Multivariate Analysis; Prevalence; Risk Factors; Stroke; United States; Vasculitis; von Willebrand Factor | 2008 |
[Effect of atorvastatin treatment on the hemorheologic and hemostatic parameters in chronic cerebrovascular patients].
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Blood Viscosity; Cerebrovascular Disorders; Chronic Disease; Drug Administration Schedule; Endothelium, Vascular; Erythrocyte Aggregation; Erythrocyte Deformability; Female; Fibrinogen; Hematocrit; Hemorheology; Hemostasis; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyrroles; Stroke; von Willebrand Factor | 2008 |
Associations of proinflammatory cytokines with the risk of recurrent stroke.
Topics: Acute-Phase Reaction; Aged; Biomarkers; Brain Ischemia; C-Reactive Protein; Case-Control Studies; Cerebral Hemorrhage; Cytokines; Female; Fibrinogen; Humans; Interleukin-18; Interleukin-6; Male; Middle Aged; Multivariate Analysis; Recurrence; Risk Factors; Stroke; Tumor Necrosis Factor-alpha | 2008 |
Variation in fibrinogen FGG and FGA genes and risk of stroke: the Rotterdam Study.
Topics: Aged; Cerebral Hemorrhage; Cohort Studies; Female; Fibrinogen; Genetic Predisposition to Disease; Genetic Variation; Haplotypes; Humans; Male; Middle Aged; Netherlands; Peptide Fragments; Polymorphism, Single Nucleotide; Prospective Studies; Risk Factors; Stroke | 2008 |
Strongly increased levels of fibrinogen elastase degradation products in patients with ischemic stroke.
Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Case-Control Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Ischemic Attack, Transient; Lymphocyte Activation; Male; Middle Aged; Odds Ratio; Pancreatic Elastase; Risk; Stroke | 2008 |
Genetic variation in fibrinogen; its relationship to fibrinogen levels and the risk of myocardial infarction and ischemic stroke.
Topics: Adolescent; Adult; Alleles; Case-Control Studies; Female; Fibrinogen; Genetic Variation; Genotype; Humans; Middle Aged; Myocardial Infarction; Odds Ratio; Polymorphism, Single Nucleotide; Risk; Stroke; Thrombosis | 2009 |
Fibrinogen independently predicts the development of ischemic stroke in a Taiwanese population: CVDFACTS study.
Topics: Adult; Aged; Antithrombin III; Biomarkers; Brain Ischemia; Factor VII; Female; Fibrinogen; Humans; Hyperlipidemias; Insurance Claim Review; Male; Middle Aged; Obesity; Predictive Value of Tests; Prospective Studies; Risk Factors; Smoking; Stroke; Taiwan; Young Adult | 2009 |
Is plasma fibrinogen useful in evaluating ischemic stroke patients?: why, how, and when.
Topics: Biomarkers; Brain Ischemia; Fibrinogen; Humans; Predictive Value of Tests; Prognosis; Reference Values; Stroke | 2009 |
Hyperfibrinogenemia and functional outcome from acute ischemic stroke.
Topics: Acute Disease; Aged; Cerebral Hemorrhage; Disability Evaluation; Factor Analysis, Statistical; Female; Fibrinogen; Humans; Male; Middle Aged; Stroke; Survival; Treatment Outcome | 2009 |
Elevated plasma fibrin D-dimer as a risk factor for vascular dementia: the Three-City cohort study.
Topics: Age Factors; Aged; Biomarkers; Cohort Studies; Dementia, Vascular; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Incidence; Male; Peripheral Vascular Diseases; Prospective Studies; Risk Factors; Stroke; von Willebrand Factor | 2009 |
Leukocyte count is associated with incidence of coronary events, but not with stroke: a prospective cohort study.
Topics: Adult; Cardiovascular Diseases; Coronary Disease; Female; Fibrinogen; Humans; Incidence; Leukocyte Count; Male; Middle Aged; Prospective Studies; Risk Factors; Sex Factors; Smoking; Stroke; Sweden | 2010 |
The associations of interleukin-6 (IL-6) and downstream inflammatory markers with risk of cardiovascular disease: the Caerphilly Study.
Topics: alpha-Macroglobulins; Biomarkers; Blood Viscosity; C-Reactive Protein; Coronary Disease; Fibrinogen; Humans; Inflammation; Interleukin-6; Leukocyte Count; Male; Middle Aged; Prospective Studies; Risk Factors; Smoking; Stroke; United Kingdom | 2010 |
Prognostic values of lesion volume and biochemical markers in ischemic and hemorrhagic stroke: a stereological and clinical study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Brain; Brain Ischemia; Disability Evaluation; Female; Fibrinogen; Humans; Intracranial Hemorrhages; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Prognosis; Stroke; Time Factors; Young Adult | 2009 |
Fibrin clot properties in acute ischemic stroke: relation to neurological deficit.
Topics: Acute Disease; Aged; Blood Coagulation Tests; Family; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Intracranial Thrombosis; Ischemia; Male; Middle Aged; Permeability; Stroke; Thrombosis | 2010 |
Factor XIII Val34Leu polymorphism and ischaemic stroke in patients with patent foramen ovale.
Topics: Adult; Amino Acid Substitution; Case-Control Studies; Factor V; Factor XIII; Female; Fibrinogen; Foramen Ovale, Patent; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Single Nucleotide; Prothrombin; Stroke | 2009 |
Interaction between fibrinogen and IL-6 genetic variants and associations with cardiovascular disease risk in the Cardiovascular Health Study.
Topics: Aged; Cardiovascular Diseases; Carotid Arteries; Female; Fibrinogen; Genetic Predisposition to Disease; Genetic Variation; Humans; Interleukin-6; Male; Models, Biological; Myocardial Infarction; Polymorphism, Single Nucleotide; Risk; Stroke | 2010 |
[Influencing factors for cerebral microbleeds in patients with acute ischemic stroke].
Topics: Aged; Brain; Brain Ischemia; Cerebral Hemorrhage; Female; Fibrinogen; Humans; Male; Middle Aged; Prevalence; Prospective Studies; Risk Factors; Stroke | 2010 |
Does the progeny of premature ischemic stroke sufferers need intensive interest of physicians oriented toward primary prevention? A pilot study.
Topics: Adult; Age of Onset; Analysis of Variance; Biomarkers; Brain Ischemia; Case-Control Studies; Female; Fibrinogen; Genetic Predisposition to Disease; Heredity; Homocysteine; Humans; Lipids; Logistic Models; Male; Odds Ratio; Pedigree; Phenotype; Pilot Projects; Poland; Primary Prevention; Risk Assessment; Risk Factors; Stroke; Young Adult | 2010 |
Management of thrombolysis-associated symptomatic intracerebral hemorrhage.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Cerebral Hemorrhage; Female; Fibrinogen; Hospital Mortality; Humans; Logistic Models; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Retrospective Studies; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome | 2010 |
Association between lipids and fibrinogen levels and ischemic stroke in the population of the Polish children with arteriopathy and cardiac disorders.
Topics: Adolescent; Child; Cohort Studies; Comorbidity; Female; Fibrinogen; Heart Diseases; Humans; Lipid Metabolism; Male; Peripheral Vascular Diseases; Poland; Risk Factors; Stroke; Triglycerides | 2010 |
The relationship between insulin resistance and hypercoagulability in acute ischemic stroke.
Topics: Aged; Female; Fibrinogen; Humans; Insulin Resistance; Male; Middle Aged; Neurologic Examination; Protein C; Protein S; Severity of Illness Index; Statistics as Topic; Stroke; Thrombophilia; von Willebrand Factor | 2010 |
Decreased fibrin network permeability and impaired fibrinolysis in the acute and convalescent phase of ischemic stroke.
Topics: Aged; Aged, 80 and over; Biomarkers; Blood Coagulation Tests; Blood Platelets; Brain Ischemia; Case-Control Studies; Female; Fibrin; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Permeability; Plasminogen Activator Inhibitor 1; Stroke; Sweden; Thromboplastin; Time Factors | 2011 |
Albumin level and stroke. Potential association between lower albumin level and cardioembolic aetiology.
Topics: Aged; Biomarkers; Brain Ischemia; C-Reactive Protein; Embolism; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hospital Mortality; Humans; Male; Serum Albumin; Stroke | 2011 |
Hemostatic markers are associated with the risk and prognosis of atrial fibrillation: the ARIC study.
Topics: Antithrombin III; Atrial Fibrillation; Biomarkers; Brain Ischemia; Factor VII; Factor VIII; Female; Fibrinogen; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Partial Thromboplastin Time; Prognosis; Protein C; Risk Factors; Stroke; von Willebrand Factor | 2012 |
Association of circulating inflammatory markers with recurrent vascular events after stroke: a prospective cohort study.
Topics: Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Female; Fibrinogen; Follow-Up Studies; Humans; Inflammation Mediators; Interleukin-6; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Retrospective Studies; Risk Factors; Stroke | 2011 |
γ'/total fibrinogen ratio is associated with short-term outcome in ischaemic stroke.
Topics: Aged; Female; Fibrinogen; Fibrinogens, Abnormal; Humans; Ischemia; Male; Middle Aged; Odds Ratio; Prognosis; Prospective Studies; Regression Analysis; Risk Factors; Stroke; Treatment Outcome | 2011 |
Mendelian randomisation: a tool for assessing causality in observational epidemiology.
Topics: Alcohol Drinking; Blood Pressure; Causality; Coronary Disease; Fibrinogen; Homocysteine; Humans; Mendelian Randomization Analysis; Molecular Epidemiology; Stroke | 2011 |
Additional impact of morning haemostatic risk factors and morning blood pressure surge on stroke risk in older Japanese hypertensive patients.
Topics: Aged; Aged, 80 and over; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Fibrinogen; Hemostasis; Humans; Hypertension; Male; Middle Aged; Peptide Fragments; Plasminogen Activator Inhibitor 1; Prospective Studies; Prothrombin; Stroke; Time Factors | 2011 |
Antihypertensive drugs and inflammation in acute ischemic stroke as a predictor factor of future cardiovascular mortality.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; C-Reactive Protein; Female; Fibrinogen; Follow-Up Studies; Humans; Hypertension; Inflammation; Male; Middle Aged; Prognosis; Prospective Studies; Stroke | 2012 |
Antithrombin III associated with fibrinogen predicts the risk of cerebral ischemic stroke.
Topics: Adult; Aged; Antithrombin III; Biomarkers; Brain Ischemia; C-Reactive Protein; Costs and Cost Analysis; Diabetes Mellitus; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolytic Agents; Humans; Hyperlipidemias; Male; Middle Aged; Predictive Value of Tests; Risk Factors; Stroke; Thrombin; Tissue Plasminogen Activator | 2011 |
[Peripheral blood indicators of inflammatory response during the first twenty-four hours of ischemic stroke].
Topics: Aged; Biomarkers; Brain Ischemia; C-Reactive Protein; Diabetes Mellitus, Type 2; Dyslipidemias; Female; Fibrinogen; Humans; Hypertension; Inflammation Mediators; Leukocyte Count; Male; Stroke; Tumor Necrosis Factor-alpha | 2010 |
[The prognostic significance of fibrinogen concentration in patients with ischemic stroke without thrombolytic treatment].
Topics: Aged; Cerebral Hemorrhage; Female; Fibrinogen; Humans; Intracranial Hemorrhages; Male; Middle Aged; Prognosis; Stroke; Thrombolytic Therapy | 2010 |
Circulating activated factor XI and active tissue factor as predictors of worse prognosis in patients following ischemic cerebrovascular events.
Topics: Adult; Age Factors; Blood Coagulation Tests; Brain Ischemia; Factor XIa; Female; Fibrinogen; Humans; Interleukin-6; Ischemic Attack, Transient; Male; Middle Aged; Predictive Value of Tests; Prognosis; Stroke; Thrombophilia; Thromboplastin; Young Adult | 2011 |
Incremental value of biochemical and echocardiographic measures in prediction of ischemic stroke: the Strong Heart Study.
Topics: Aged; Albuminuria; Brain Ischemia; C-Reactive Protein; Cardiovascular Diseases; Cohort Studies; Creatinine; Data Interpretation, Statistical; Echocardiography; Female; Fibrinogen; Follow-Up Studies; Glycated Hemoglobin; Heart; Heart Atria; Humans; Indians, North American; Kidney Diseases; Male; Middle Aged; Risk Factors; Stroke | 2012 |
Biomarkers of inflammation and endothelial dysfunction in stroke with and without sleep apnea.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Endothelium, Vascular; Female; Fibrinogen; Humans; Inflammation; Intercellular Adhesion Molecule-1; Lymphotoxin-alpha; Male; Middle Aged; Neurologic Examination; Polysomnography; Receptors, Interleukin-4; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; Risk Factors; Sleep Apnea Syndromes; Stroke; Vascular Cell Adhesion Molecule-1; Vascular Diseases | 2012 |
Study of hemostatic biomarkers in acute ischemic stroke by clinical subtype.
Topics: Antithrombin III; Biomarkers; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Intracranial Thrombosis; Male; Prognosis; Stroke | 2012 |
Creation of fibrinogen-enhanced experimental blood clots to evaluate mechanical thrombectomy devices for treatment of acute stroke: an in vitro study.
Topics: Animals; Blood Coagulation; Cell Adhesion; Elasticity; Equipment Design; Erythrocytes; Fibrinogen; Materials Testing; Stroke; Swine; Tensile Strength; Thrombectomy; Thrombin | 2012 |
[Gene-determined hemocoagulation disease as a cause of ischemic stroke in children].
Topics: Alleles; Blood Coagulation Disorders; Child; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Integrin alpha2; Male; Mutation; Plasminogen Activator Inhibitor 1; Stroke; Thrombosis | 2011 |
[Changes of haemostatic parameters in patients with acute cardioembolic stroke].
Topics: Adult; Aged; Antifibrinolytic Agents; Antithrombin III; Arteriosclerosis; Brain Ischemia; Embolism; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Heart Diseases; Hemostasis; Humans; Male; Middle Aged; Plasminogen; Plasminogen Activators; Platelet Aggregation; Serum Globulins; Stroke; Thrombin; von Willebrand Factor | 2011 |
Platelets and acute cerebral infarction.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Blood Platelets; Cerebral Infarction; Female; Fibrinogen; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Neutrophils; P-Selectin; Platelet Activation; Platelet Count; Prospective Studies; Protein Binding; Stroke | 2013 |
Relationship between acute stroke outcome, aspirin resistance, and humoral factors.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Aspirin; C-Reactive Protein; Drug Resistance; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Intercellular Adhesion Molecule-1; Male; Middle Aged; P-Selectin; Platelet Function Tests; Prospective Studies; Stroke; von Willebrand Factor | 2012 |
[The balance of markers of regulation vascular tone and fibrinogen in the prognosis of hemorrhagic transformation and fatal outcome in the acute period of ischemic stroke].
Topics: Aged; Aged, 80 and over; Biomarkers; Blood Coagulation; Brain Ischemia; Cerebral Hemorrhage; Chymosin; Endothelin-1; Female; Fibrinogen; Humans; Male; Middle Aged; Natriuretic Peptide, C-Type; Predictive Value of Tests; Prognosis; Stroke; Survival Analysis; Vasomotor System | 2012 |
Cocktail blood biomarkers: prediction of clinical outcomes in patients with acute ischemic stroke.
Topics: Aged; Biomarkers; Brain Ischemia; Cytokines; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Inflammation; Male; Middle Aged; Predictive Value of Tests; Prognosis; Stroke | 2013 |
[Fibrinogen concentration in the evaluation of safety and efficiency of thrombolytic therapy in patients with ischemic stroke].
Topics: Aged; Brain Ischemia; Female; Fibrinogen; Fibrinolytic Agents; Humans; Male; Middle Aged; Predictive Value of Tests; Recovery of Function; Severity of Illness Index; Stroke; Thrombolytic Therapy; Treatment Outcome | 2012 |
[Genetics of blood coagulation in young stroke patients].
Topics: Adult; Age of Onset; Blood Coagulation; Blood Coagulation Factors; Blood Donors; Europe; Factor V; Female; Fibrinogen; Humans; Hungary; Leucine; Male; Methylenetetrahydrofolate Reductase (NADPH2); Odds Ratio; Oxidoreductases Acting on CH-NH Group Donors; Peptidyl-Dipeptidase A; Platelet Glycoprotein GPIIb-IIIa Complex; Polymerase Chain Reaction; Polymorphism, Genetic; Proline; Prothrombin; Risk Factors; Stroke; Surveys and Questionnaires | 2002 |
Inflammation, cell adhesion molecules, and stroke: tools in pathophysiology and epidemiology?
Topics: Biomarkers; C-Reactive Protein; Case-Control Studies; Cell Adhesion Molecules; Comorbidity; Fibrinogen; Humans; Inflammation; Intercellular Adhesion Molecule-1; Predictive Value of Tests; Risk; Risk Factors; Stroke | 2002 |
C-reactive protein in ischemic stroke.
Topics: Brain Ischemia; C-Reactive Protein; Cohort Studies; Female; Fibrinogen; Humans; Male; Predictive Value of Tests; Prognosis; Risk Assessment; Risk Factors; Stroke | 2002 |
Soluble intercellular adhesion molecule-1 and risk of future ischemic stroke: a nested case-control study from the Bezafibrate Infarction Prevention (BIP) study cohort.
Topics: Bezafibrate; Biomarkers; Brain Ischemia; Case-Control Studies; Chronic Disease; Cohort Studies; Comorbidity; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Humans; Hypolipidemic Agents; Intercellular Adhesion Molecule-1; Israel; Logistic Models; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Randomized Controlled Trials as Topic; Risk; Risk Assessment; Risk Factors; Stroke | 2002 |
Prognostic implications of admission inflammatory profile in acute ischemic neurological events.
Topics: Acute Disease; Aged; Blood Sedimentation; C-Reactive Protein; Diagnostic Tests, Routine; Erythrocyte Aggregation; Female; Fibrinogen; Humans; Ischemic Attack, Transient; Male; Middle Aged; Prognosis; Risk Factors; Sampling Studies; Severity of Illness Index; Stroke | 2002 |
Von Willebrand factor, fibrinogen and other risk factors of thrombosis in patients with a history of cerebrovascular ischemic stroke and their children.
Topics: Adult; Age Distribution; Analysis of Variance; Biomarkers; Blood Chemical Analysis; Blood Pressure Determination; Case-Control Studies; Child; Child, Preschool; Cohort Studies; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Incidence; Male; Middle Aged; Predictive Value of Tests; Probability; Reference Values; Risk Factors; Sensitivity and Specificity; Sex Distribution; Statistics, Nonparametric; Stroke; Thrombosis; von Willebrand Factor | 2002 |
Influence of chronic Helicobacter pylori infection on ischemic cerebral stroke risk factors.
Topics: Aged; Antigens, Bacterial; Bacterial Proteins; Brain Ischemia; Breath Tests; Cholesterol; Cholesterol, LDL; Chronic Disease; Fibrinogen; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Interleukin-8; Middle Aged; Risk Factors; RNA, Ribosomal, 16S; Stroke | 2002 |
Atherothrombotic risk factors in subjects with a family history of stroke.
Topics: Adult; Aged; Aged, 80 and over; Arteriosclerosis; Factor VII; Female; Fibrinogen; Fibrinolysis; Humans; Male; Medical Records; Metabolic Syndrome; Middle Aged; Risk Factors; Stroke; Thrombosis; von Willebrand Factor | 2002 |
[Blood coagulation in normotensives and hypertensives in relation to their body mass index].
Topics: Adult; Blood Coagulation; Blood Coagulation Tests; Blood Pressure; Body Mass Index; Cholesterol, HDL; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Obesity; Partial Thromboplastin Time; Plasminogen Activator Inhibitor 1; Risk Factors; Stroke; Triglycerides | 2002 |
Inflammation, blood pressure, and stroke: an opportunity to target primary prevention?
Topics: Biomarkers; Blood Pressure; C-Reactive Protein; Case-Control Studies; Cholesterol; Cohort Studies; Comorbidity; Fibrinogen; Follow-Up Studies; Humans; Hypertension; Inflammation; Intercellular Adhesion Molecule-1; Interleukin-6; Male; Middle Aged; Predictive Value of Tests; Primary Prevention; Prospective Studies; Risk Factors; Stroke; Sweden | 2002 |
Long-term effects of inflammation-sensitive plasma proteins and systolic blood pressure on incidence of stroke.
Topics: Adult; alpha 1-Antitrypsin; Blood Pressure; Blood Proteins; Ceruloplasmin; Comorbidity; Diastole; Fibrinogen; Follow-Up Studies; Haptoglobins; Humans; Hypertension; Incidence; Inflammation; Male; Middle Aged; Orosomucoid; Predictive Value of Tests; Risk Assessment; Risk Factors; Stroke; Sweden; Systole; Time | 2002 |
[Study on stroke syndrome of Chinese medicine and its relationship with blood hypercoagulative status and insulin resistance in diabetic ischemic stroke patients].
Topics: Aged; Aged, 80 and over; Blood Viscosity; Diabetic Neuropathies; Diagnosis, Differential; Female; Fibrinogen; Humans; Insulin Resistance; Male; Medicine, Chinese Traditional; Middle Aged; Platelet Aggregation; Stroke | 2002 |
Fibrinogen gene promoter -455 A allele as a risk factor for lacunar stroke.
Topics: Aged; Alleles; Brain Infarction; Cerebral Arteries; Female; Fibrinogen; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Polymorphism, Genetic; Promoter Regions, Genetic; Risk Factors; Stroke | 2003 |
Fibrinogen: a predictor of stroke and marker of atherosclerosis.
Topics: Adult; Aged; Arteriosclerosis; Biomarkers; C-Reactive Protein; Fibrinogen; Humans; Middle Aged; Risk Factors; Stroke | 2003 |
Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk.
Topics: Aged; Factor XIII; Female; Fibrinogen; Genotype; Humans; Linear Models; Male; Microscopy, Electron, Scanning; Molecular Biology; Polymorphism, Genetic; Risk Factors; Stroke | 2003 |
POEMS syndrome associated with ischemic stroke.
Topics: Adult; Brain Ischemia; Female; Fibrinogen; Humans; Magnetic Resonance Imaging; Male; Middle Aged; POEMS Syndrome; Stroke | 2003 |
[Effects of cardiovascular risk factors on hemorheologic parameters in cerebrovascular patients].
Topics: Adult; Aged; Alcoholism; Blood Viscosity; Cardiovascular Diseases; Case-Control Studies; Cerebrovascular Disorders; Diabetes Complications; Erythrocyte Aggregation; Erythrocyte Deformability; Female; Fibrinogen; Hematocrit; Hemorheology; Humans; Hyperlipidemias; Male; Middle Aged; Plasma; Risk Factors; Smoking; Stroke | 2003 |
Fibrinogen changes in relation to cerebrovascular accidents.
Topics: Brain; Cardiovascular System; Fibrinogen; Humans; Stroke | 1961 |
ANTICOAGULANTS PLUS STREPTOKINASE THERAPY IN PROGRESSIVE STROKE.
Topics: Angiography; Anticoagulants; Blood Coagulation Disorders; Cerebral Hemorrhage; Deoxyribonuclease I; Drug Therapy; Fibrinogen; Heparin; Intracranial Embolism; Intracranial Embolism and Thrombosis; Streptodornase and Streptokinase; Streptokinase; Stroke; Thrombosis; Toxicology; Warfarin | 1964 |
PLASMA FIBRINOLYTIC ACTIVITY FOLLOWING RECENT MYOCARDIAL AND CEREBRAL INFARCTION.
Topics: Cerebral Infarction; Fibrinogen; Fibrinolysis; Humans; Intracranial Embolism; Intracranial Embolism and Thrombosis; Myocardial Infarction; Stroke; Thrombolytic Therapy; Thrombosis | 1965 |
Fibrinogen as predictor of ischemic stroke in patients with non-valvular atrial fibrillation.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Brain Ischemia; Fibrinogen; Humans; Middle Aged; Predictive Value of Tests; Risk Factors; Stroke | 2003 |
Hemostatic risk factors in ischemic stroke.
Topics: Adolescent; Adult; Aged; Blood Coagulation Factors; Brain Ischemia; Case-Control Studies; Female; Fibrinogen; Hemostasis; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Odds Ratio; Risk Factors; Smoking; Stroke | 2003 |
Risk of myocardial infarction and stroke in smokers is related to plasma levels of inflammation-sensitive proteins.
Topics: Adult; alpha 1-Antitrypsin; Biomarkers; Carboxyhemoglobin; Ceruloplasmin; Cohort Studies; Comorbidity; Fibrinogen; Follow-Up Studies; Haptoglobins; Humans; Inflammation; Male; Middle Aged; Motor Activity; Myocardial Infarction; Orosomucoid; Prospective Studies; Risk; Smoking; Smoking Cessation; Stroke; Surveys and Questionnaires; Sweden | 2004 |
POEMS syndrome, fibrinogen, and ischemic stroke: a critical point of view.
Topics: C-Reactive Protein; Fibrinogen; Humans; POEMS Syndrome; Risk Factors; Stroke | 2004 |
Tumor necrosis factor alpha serum levels and inflammatory response in acute ischemic stroke patients.
Topics: Aged; Aged, 80 and over; C-Reactive Protein; Case-Control Studies; Central Nervous System; Electrocardiography; Electroencephalography; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Follow-Up Studies; Humans; Inflammation; Ischemia; Leukocytes; Magnetic Resonance Imaging; Male; Middle Aged; Neurologic Examination; Neutrophils; Stroke; Time Factors; Tomography, X-Ray Computed; Tumor Necrosis Factor-alpha | 2004 |
[Migraine, inflammation, genes. New risk factors for stroke].
Topics: Adult; Arteriosclerosis; Aspirin; C-Reactive Protein; Case-Control Studies; Contraceptives, Oral; Female; Fibrinogen; Folic Acid; Humans; Hyperhomocysteinemia; Inflammation; Male; Meta-Analysis as Topic; Migraine Disorders; Risk Factors; Smoking; Stroke; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Vitamin B 12; Vitamin B 6 | 2003 |
Progression in lacunar stroke is related to elevated acute phase parameters.
Topics: Aged; Body Temperature; Brain Infarction; Case-Control Studies; Disease Progression; Female; Fibrinogen; Follow-Up Studies; Humans; Inflammation; Leukocytes; Male; Middle Aged; Motor Activity; Neurologic Examination; Neurotransmitter Agents; Prognosis; Prospective Studies; Risk Factors; Severity of Illness Index; Stroke; Time Factors | 2004 |
Coagulation studies in cerebrovascular disease. II. Cooperative study of stroke patients in Minnesota and Japan (preliminary communication).
Topics: Adolescent; Adult; Age Factors; Aged; Blood Coagulation Disorders; Blood Coagulation Tests; Cerebrovascular Disorders; Fibrinogen; Humans; Japan; Middle Aged; Minnesota; Prothrombin Time; Reference Values; Reproducibility of Results; Stroke | 1967 |
Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Topics: Aged; Biomarkers; Clinical Trials as Topic; Coronary Disease; Cross-Sectional Studies; Endothelium, Vascular; Female; Fibrinogen; Homocysteine; Humans; Hypertension; Male; Middle Aged; Outcome Assessment, Health Care; P-Selectin; Platelet Activation; Risk Factors; Stroke; von Willebrand Factor | 2004 |
Incidence of obesity-associated cardiovascular disease is related to inflammation-sensitive plasma proteins: a population-based cohort study.
Topics: Adult; alpha 1-Antitrypsin; Biomarkers; Blood Proteins; Body Mass Index; Cardiovascular Diseases; Ceruloplasmin; Cohort Studies; Fibrinogen; Follow-Up Studies; Haptoglobins; Humans; Hypertension; Incidence; Inflammation; Male; Middle Aged; Motor Activity; Myocardial Infarction; Obesity; Orosomucoid; Predictive Value of Tests; Proportional Hazards Models; Smoking; Stroke; Sweden | 2004 |
[Association between the polymorphism of beta-fibrinogen gene -455G/A and ischemic stroke].
Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Female; Fibrinogen; Humans; Hypertension; Male; Middle Aged; Polymorphism, Genetic; Stroke | 2004 |
Fibrinogen concentration and risk of ischemic stroke and acute coronary events in 5113 patients with transient ischemic attack and minor ischemic stroke.
Topics: Aged; Female; Fibrinogen; Humans; Ischemic Attack, Transient; Male; Meta-Analysis as Topic; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Risk Factors; Stroke | 2004 |
The -148 C/T fibrinogen gene polymorphism and fibrinogen levels in ischaemic stroke: a case-control study.
Topics: Adolescent; Adult; Aged; Brain Ischemia; Case-Control Studies; Female; Fibrinogen; Genotype; Humans; Male; Middle Aged; Polymorphism, Genetic; Promoter Regions, Genetic; Stroke | 2005 |
A pilot dose-escalation safety study of tenecteplase in acute ischemic stroke.
Topics: Aged; Drug Administration Schedule; Female; Fibrinogen; Follow-Up Studies; Humans; Ischemic Attack, Transient; Male; Pilot Projects; Safety; Stroke; Tenecteplase; Time Factors; Tissue Plasminogen Activator; Tomography, X-Ray Computed; Treatment Outcome | 2005 |
[Risk factors for stroke: epidemiological evidence from Japan].
Topics: Adult; Age Factors; Aged; Cerebral Hemorrhage; Cholesterol; Diabetes Complications; Female; Fibrinogen; Humans; Japan; Male; Middle Aged; Risk Factors; Stress, Psychological; Stroke | 2005 |
Risk factors for first-ever acute ischemic non-embolic stroke in elderly individuals.
Topics: Acute Disease; Aged; Aged, 80 and over; Brain Ischemia; Case-Control Studies; Cholesterol; Female; Fibrinogen; Greece; Humans; Hyperlipidemias; Incidence; Male; Retrospective Studies; Risk Factors; Smoking; Stroke; Uric Acid | 2005 |
[Hemostatic and fibrinolysis markers in the early phase of acute ischaemic stroke].
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Case-Control Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Peptide Fragments; Prothrombin; Stroke; Time Factors | 2004 |
Predictors of good outcome in medium to large spontaneous supratentorial intracerebral haemorrhages.
Topics: Aged; Blood Pressure; Body Temperature; C-Reactive Protein; Cerebral Hemorrhage; Female; Fibrinogen; Follow-Up Studies; Hemiplegia; Humans; Male; Neurosurgical Procedures; Neutrophils; Patient Selection; Prospective Studies; Severity of Illness Index; Stroke; Tomography, X-Ray Computed; Treatment Outcome | 2005 |
Components of the metabolic syndrome and risk for first-ever acute ischemic nonembolic stroke in elderly subjects.
Topics: Aged; Apolipoprotein A-I; Brain Ischemia; Case-Control Studies; Cholesterol; Cholesterol, HDL; Diabetes Complications; Diabetes Mellitus; Female; Fibrinogen; Humans; Hypertension; Ischemia; Lipoprotein(a); Lipoproteins, HDL; Logistic Models; Male; Metabolic Syndrome; Obesity; Odds Ratio; Regression Analysis; Risk Factors; Stroke; Triglycerides; Uric Acid | 2005 |
Assessment of relations between clinical outcome of ischemic stroke and activity of inflammatory processes in the acute phase based on examination of selected parameters.
Topics: Acute-Phase Proteins; Acute-Phase Reaction; Adult; Aged; Aged, 80 and over; Analysis of Variance; C-Reactive Protein; Case-Control Studies; Female; Fibrinogen; Humans; Immunoglobulin G; Inflammation; Leukocyte Count; Leukocytes; Male; Middle Aged; Neurologic Examination; Severity of Illness Index; Stroke; Time Factors; Trisaccharides | 2005 |
Inflammatory response after acute ischemic stroke.
Topics: Aged; Analysis of Variance; C-Reactive Protein; Female; Fibrinogen; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Risk Factors; Stroke; Time Factors | 2005 |
Risk factors for cardiovascular event recurrence in the Atherosclerosis Risk in Communities (ARIC) study.
Topics: Atherosclerosis; Blood Pressure; Carotid Arteries; Cholesterol; Coronary Disease; Creatinine; Female; Fibrinogen; Follow-Up Studies; Humans; Hypertension; Leukocyte Count; Lipoprotein(a); Male; Middle Aged; Recurrence; Risk Factors; Serum Albumin; Smoking; Stroke; Tunica Intima; Tunica Media; Ultrasonography; Waist-Hip Ratio | 2005 |
[Assessment of metabolic atherosclerosis risk factors in progeny of patients with past ischemic stroke].
Topics: Adult; Apolipoprotein A-I; Apolipoproteins B; Biomarkers; Brain Ischemia; C-Reactive Protein; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Female; Fibrinogen; Folic Acid; Genetic Predisposition to Disease; Homocysteine; Humans; Life Style; Lipoprotein(a); Male; Risk Factors; Stroke; Time Factors; Triglycerides; von Willebrand Factor | 2005 |
Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly Study.
Topics: Aged; Biomarkers; Coronary Disease; Factor VIII; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Myocardial Ischemia; Plasminogen Activator Inhibitor 1; Predictive Value of Tests; Risk Factors; Stroke; Tissue Plasminogen Activator; United Kingdom; von Willebrand Factor | 2005 |
Genetic risk factors for arterial thrombosis and inflammation.
Topics: Arteries; Factor V; Factor VIII; Fibrinogen; Genetic Predisposition to Disease; Genetic Variation; Hemostasis; Humans; Inflammation; Myocardial Infarction; Risk Factors; Stroke; Thrombosis | 2005 |
Occupation, marital status, and low-grade inflammation: mutual confounding or independent cardiovascular risk factors?
Topics: Adult; alpha 1-Antitrypsin; Biomarkers; Ceruloplasmin; Cohort Studies; Coronary Artery Disease; Fibrinogen; Haptoglobins; Humans; Incidence; Inflammation; Male; Marital Status; Middle Aged; Occupations; Orosomucoid; Risk Factors; Social Class; Stroke | 2006 |
Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: a 5-year follow-up study.
Topics: Aged; Analysis of Variance; Atherosclerosis; C-Reactive Protein; Cardiovascular Diseases; Cardiovascular System; Carotid Arteries; Carotid Artery Diseases; Chlamydophila pneumoniae; Cytomegalovirus; Disease Progression; Echocardiography, Doppler; Female; Fibrinogen; Follow-Up Studies; Helicobacter pylori; Humans; Immunoglobulin G; Infections; Inflammation; Lipids; Male; Middle Aged; Risk Factors; Sex Factors; Stroke; Time Factors; Tunica Intima; Tunica Media; Ultrasonography | 2006 |
Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: the Strong Heart Study (SHS).
Topics: Aged; Algorithms; C-Reactive Protein; Cardiomegaly; Cohort Studies; Coronary Disease; Echocardiography; Female; Fibrinogen; Follow-Up Studies; Heart Atria; Heart Failure; Humans; Indians, North American; Male; Middle Aged; Myocardial Infarction; Risk Factors; Sex Factors; Stroke; United States | 2006 |
Association studies of genetic polymorphism, environmental factors and their interaction in ischemic stroke.
Topics: Adult; Aged; Aged, 80 and over; Alcohol Drinking; Apolipoproteins E; Asian People; Brain Ischemia; Case-Control Studies; Disease Susceptibility; Female; Fibrinogen; Genotype; Humans; Hypertension; Incidence; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Renin; Risk Factors; Smoking; Stroke | 2006 |
Hypercoagulopathy in stroke patients with nonvalvular atrial fibrillation: hematologic and cardiologic investigations.
Topics: Aged; Atrial Fibrillation; Case-Control Studies; Drug Evaluation; Female; Fibrinogen; Humans; Middle Aged; Peptide Fragments; Prothrombin; Severity of Illness Index; Stroke; Thrombophilia | 2006 |
Metabolic syndrome and the risk of stroke in middle-aged men.
Topics: Adult; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cholesterol, LDL; Cohort Studies; Diabetes Complications; Fibrinogen; Finland; Follow-Up Studies; Humans; Male; Metabolic Syndrome; Middle Aged; Prospective Studies; Risk; Risk Factors; Smoking; Stroke; Time Factors | 2006 |
Hypofibrinogenaemia resulting from novel single nucleotide deletion at codon Bbeta58 (3404del A) associated with thrombotic stroke in infancy.
Topics: Adolescent; Adult; Afibrinogenemia; Amino Acid Sequence; Base Sequence; Family Health; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Male; Molecular Sequence Data; Point Mutation; Stroke; Thrombosis | 2006 |
[A linkage between beta-fibrinogen gene -148C/T polymorphism and cerebral infarction].
Topics: Adult; Aged; Aged, 80 and over; Alleles; Asian People; Cerebral Infarction; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Polymorphism, Genetic; Stroke; Young Adult | 2006 |
Should neurologists measure fibrinogen concentrations?
Topics: Biomarkers; Fibrinogen; Gene Expression; Humans; Stroke; Treatment Outcome | 2006 |
Increased plasma fibrinogen predicts one-year mortality in patients with acute ischemic stroke.
Topics: Acute Disease; Age Factors; Aged; Biomarkers; Female; Fibrinogen; Humans; Leukocyte Count; Male; Middle Aged; Multivariate Analysis; Platelet Aggregation Inhibitors; Predictive Value of Tests; Sex Factors; Stroke; Survival Analysis | 2006 |
[A related analysis for alpha, beta fibrinogen gene haplotypes and nucleotide polymorphisms associated with the ischemic stroke in Hainan Han population].
Topics: Alleles; Brain Ischemia; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Linkage Disequilibrium; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Stroke | 2006 |
Wide-range C-reactive protein efficacy in acute ischemic stroke patients.
Topics: Acute Disease; Aged; Aged, 80 and over; Biomarkers; Blood Sedimentation; Brain Ischemia; C-Reactive Protein; Female; Fibrinogen; Humans; Leukocyte Count; Male; Middle Aged; Predictive Value of Tests; Stroke | 2006 |
A longitudinal population-based study of prothrombotic factors in elderly subjects with atrial fibrillation: the Rotterdam Study 1990-1999.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Blood Coagulation Factors; Case-Control Studies; Cohort Studies; Death; Female; Fibrinogen; Humans; Longitudinal Studies; Male; Netherlands; P-Selectin; Proportional Hazards Models; Risk Factors; Stroke; Thrombophilia; Thrombosis; von Willebrand Factor | 2006 |
Role of fibrinogen levels and factor XIII V34L polymorphism in thrombolytic therapy in stroke patients.
Topics: Aged; Aged, 80 and over; Brain Ischemia; Cohort Studies; Factor XIII; Female; Fibrinogen; Hemorrhage; Humans; Leucine; Male; Middle Aged; Polymorphism, Genetic; Prospective Studies; Stroke; Thrombolytic Therapy; Treatment Outcome; Valine | 2006 |
Contribution of the -455G/A polymorphism at beta-fibrinogen gene and of the Leiden mutation to hemorheological parameters in ischemic stroke patients.
Topics: Aged; Blood Viscosity; Brain Ischemia; Chi-Square Distribution; Factor V; Female; Fibrinogen; Genotype; Hemorheology; Humans; Male; Middle Aged; Odds Ratio; Polymorphism, Genetic; Smoking; Stroke | 2006 |
Plasma fibrinogen concentrations and risk of stroke and its subtypes among Japanese men and women.
Topics: Adult; Aged; Brain Ischemia; Cerebral Hemorrhage; Cohort Studies; Comorbidity; Confounding Factors, Epidemiologic; Female; Fibrinogen; Follow-Up Studies; Health Surveys; Humans; Incidence; Japan; Male; Middle Aged; Population Surveillance; Proportional Hazards Models; Prospective Studies; Risk Factors; Smoking; Stroke; Subarachnoid Hemorrhage | 2006 |
Levels of acute phase proteins remain stable after ischemic stroke.
Topics: Acute-Phase Reaction; Adult; Aged; C-Reactive Protein; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Serum Amyloid A Protein; Statistics, Nonparametric; Stroke; Time Factors | 2006 |
Preoperative serum fibrinogen as a predictor of myocardial infarction in the surgical myocardial revascularization.
Topics: Biomarkers; Cohort Studies; Female; Fibrinogen; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Predictive Value of Tests; Pulmonary Embolism; Retrospective Studies; Stroke | 2006 |
[Hemostatic markers of endothelial injury in ischaemic stroke caused by large or small vessel disease].
Topics: beta-Thromboglobulin; Biomarkers; Blood Coagulation Factors; Brain Ischemia; Cerebral Arteries; Cerebral Veins; Endothelium, Vascular; Female; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Radiography; Stroke; Tissue Plasminogen Activator; von Willebrand Factor | 2006 |
Rosuvastatin treatment prevents progressive kidney inflammation and fibrosis in stroke-prone rats.
Topics: Actins; Animals; Blood Pressure; Blotting, Western; Collagen; Disease Progression; Fibrinogen; Fibrinolysin; Fibrosis; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Kidney; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Microscopy, Electron; Plasminogen Activator Inhibitor 1; Plasminogen Activators; Podocytes; Proteinuria; Pyrimidines; Rats; Rats, Inbred SHR; Rosuvastatin Calcium; Simvastatin; Stroke; Sulfonamides | 2007 |
C-reactive protein and fibrinogen in acute stroke patients with and without sleep apnea.
Topics: Acute Disease; Aged; C-Reactive Protein; Cross-Sectional Studies; Female; Fibrinogen; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Prospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index; Sleep Apnea Syndromes; Stroke | 2007 |
Role of serum fibrinogen in patients of ischemic cerebrovascular disease.
Topics: Acute Disease; Brain Ischemia; Case-Control Studies; Female; Fibrinogen; Humans; Male; Middle Aged; Risk Factors; Smoking; Stroke | 2007 |
Common variation in the C-terminal region of the fibrinogen beta-chain: effects on fibrin structure, fibrinolysis and clot rigidity.
Topics: Amino Acid Substitution; Animals; Chlorocebus aethiops; Coronary Artery Disease; COS Cells; Fibrin; Fibrinogen; Fibrinolysis; Humans; Models, Molecular; Polymorphism, Genetic; Protein Structure, Tertiary; Recombinant Proteins; Stroke | 2008 |
Effect of age and glycaemic control on the association between fibrinogen and risk of acute coronary events after transient ischaemic attack or stroke.
Topics: Age Factors; Aged; Blood Glucose; Cohort Studies; Death, Sudden, Cardiac; Female; Fibrinogen; Humans; Ischemic Attack, Transient; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Risk Factors; Stroke | 2008 |
Usefulness of inflammatory and haemostatic markers to predict short-term risk for death in middle-aged ischaemic stroke patients.
Topics: Biomarkers; Brain Ischemia; C-Reactive Protein; Encephalitis; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Regression Analysis; Risk; Stroke; Thrombophilia; Tumor Necrosis Factor-alpha | 2008 |
The relationship between serum levels of vascular calcification inhibitors and carotid plaque vulnerability.
Topics: Aged; Biomarkers; Blood Pressure; Body Size; C-Reactive Protein; Carotid Stenosis; Case-Control Studies; Cross-Sectional Studies; Female; Fibrinogen; Greece; Humans; Ischemic Attack, Transient; Leukocyte Count; Lipids; Logistic Models; Magnetic Resonance Angiography; Male; Middle Aged; Osteopontin; Osteoprotegerin; Stroke; Tomography, X-Ray Computed; Ultrasonography, Doppler, Color; Up-Regulation | 2008 |
Persistent hyperfibrinogenemia in acute ischemic stroke / transient ischemic attack (TIA).
Topics: Aged; Blood Sedimentation; Brain Ischemia; C-Reactive Protein; Case-Control Studies; Disease Progression; Female; Fibrinogen; Follow-Up Studies; Humans; Ischemic Attack, Transient; Leukocyte Count; Male; Middle Aged; Prognosis; Stroke; Time Factors; Up-Regulation | 2008 |
Associations between common fibrinogen gene polymorphisms and cardiovascular disease in older adults. The Cardiovascular Health Study.
Topics: Age Factors; Aged; Black or African American; Brain Ischemia; Cardiovascular Diseases; Carotid Artery Diseases; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Haplotypes; Humans; Male; Myocardial Infarction; Polymorphism, Single Nucleotide; Population Surveillance; Proportional Hazards Models; Prospective Studies; Reproducibility of Results; Risk Assessment; Risk Factors; Sex Factors; Stroke; United States; White People | 2008 |
Fibrinogen gene variation and ischemic stroke.
Topics: Case-Control Studies; Female; Fibrinogen; Genetic Variation; Genotype; Haplotypes; Humans; Ischemia; Linkage Disequilibrium; Male; Models, Genetic; Multigene Family; Odds Ratio; Polymorphism, Single Nucleotide; Stroke | 2008 |
Hemorheological disturbances and cognitive function in patients with cerebrovascular disease.
Topics: Adult; Aged; Blood Viscosity; Cerebral Infarction; Cerebrovascular Disorders; Cognition; Female; Fibrinogen; Hematocrit; Hemorheology; Humans; Ischemic Attack, Transient; Male; Middle Aged; Stroke | 2008 |
Plasma fibrinogen and its correlates in elderly Japanese men living in Japan and Hawaii.
Topics: Aged; Aged, 80 and over; Asian; California; Cholesterol, HDL; Coronary Disease; Cross-Sectional Studies; Fibrinogen; Hawaii; Hematocrit; Humans; Japan; Leukocyte Count; Life Style; Male; Middle Aged; Prevalence; Retrospective Studies; Risk Factors; Stroke; Triglycerides | 1999 |
Markers of thrombin and platelet activity in patients with atrial fibrillation: correlation with stroke among 1531 participants in the stroke prevention in atrial fibrillation III study.
Topics: Age Factors; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; beta-Thromboglobulin; Biomarkers; Factor V; Female; Fibrinogen; Fibrinolytic Agents; Humans; Male; Middle Aged; Multivariate Analysis; Peptide Fragments; Phlebotomy; Prothrombin; Sex Factors; Stroke; Thromboembolism; Warfarin | 1999 |
Association of the platelet glycoprotein IIb HPA-3 polymorphism with survival after acute ischemic stroke.
Topics: Aged; Antigens, Human Platelet; beta-Thromboglobulin; Case-Control Studies; Female; Fibrinogen; Genotype; Humans; Male; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Membrane Glycoproteins; Polymorphism, Genetic; Receptors, Cell Surface; Stroke | 1999 |
Natural statins and stroke.
Topics: Anticholesteremic Agents; Atorvastatin; Cholesterol, LDL; Fibrinogen; Heptanoic Acids; Humans; Pyrroles; Risk Factors; Stroke | 2000 |
Comparative values of erythrocyte aggregability versus other indices of hemorheological disorders in patients with ischemic brain infarcts.
Topics: Adult; Aged; Blood Viscosity; Brain Infarction; Erythrocyte Aggregation; Erythrocyte Deformability; Female; Fibrinogen; Hematocrit; Hemorheology; Humans; Hypoxia-Ischemia, Brain; Male; Middle Aged; Severity of Illness Index; Stroke | 2000 |
Does hypertension confer a hypercoagulable state in stroke-prone spontaneously hypertensive rats?
Topics: Animals; Blood Cell Count; Blood Coagulation; Blood Coagulation Disorders; Carrier Proteins; Complement C1 Inactivator Proteins; Escherichia coli Proteins; Factor Xa; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hypertension; Lipoproteins; Male; Membrane Transport Proteins; Partial Thromboplastin Time; Protein C; Prothrombin Time; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Stroke | 2000 |
Plasma fibrinogen of black South Africans: the BRISK study.
Topics: Adolescent; Adult; Age Factors; Black People; Body Mass Index; Coronary Disease; Cross-Sectional Studies; Female; Fibrinogen; Health Surveys; Humans; Incidence; Male; Middle Aged; Regression Analysis; Risk Factors; Sex Factors; South Africa; Stroke | 1998 |
The renin-angiotensin-aldosterone system and carotid artery disease in mild-to-moderate primary hypertension.
Topics: Adult; Aged; Aging; Carotid Arteries; Carotid Artery Diseases; Female; Fibrinogen; Humans; Hypertension; Male; Middle Aged; Renin; Renin-Angiotensin System; Stroke; Tunica Intima | 2000 |
Protein C deficiency related to valproic acid therapy: a possible association with childhood stroke.
Topics: Anticonvulsants; Antithrombins; Child; Child, Preschool; Female; Fibrinogen; Humans; Infant; Platelet Count; Protein C; Protein C Deficiency; Protein S; Seizures; Stroke; Valproic Acid | 2000 |
Fibrinogen levels and obstructive sleep apnea in ischemic stroke.
Topics: Aged; Brain Ischemia; Female; Fibrinogen; Humans; Linear Models; Male; Middle Aged; Polysomnography; Risk Factors; Sleep Apnea, Obstructive; Stroke; Time Factors | 2000 |
A global platelet test of thrombosis and thrombolysis detects a prothrombotic state in some patients with non-insulin dependent diabetes and in some patients with stroke.
Topics: Adult; Age Factors; Aged; Antifibrinolytic Agents; Arteriosclerosis; Diabetes Mellitus, Type 2; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Function Tests; Stress, Mechanical; Stroke; Thrombophilia | 2000 |
[Acute phase response after stroke: differences between ischemic stroke and intracerebral hemorrhage].
Topics: Acute-Phase Reaction; Aged; Brain Infarction; Female; Fibrinogen; Humans; Intracranial Hemorrhages; Leukocytes; Male; Stroke | 2001 |
[Coping with stress and blood viscosity in stroke prevention patients].
Topics: Adaptation, Psychological; Aggression; Austria; Blood Viscosity; Defense Mechanisms; Female; Fibrinogen; Hematocrit; Humans; Male; Personality Tests; Reference Values; Risk Factors; Stress, Psychological; Stroke | 2001 |
Effects of inducible nitric oxide synthase inhibition on cerebral edema in severe hypertension.
Topics: Animals; Brain Edema; Cerebral Cortex; Fibrinogen; Glial Fibrillary Acidic Protein; Hypertension; Intercellular Adhesion Molecule-1; Isothiuronium; Male; Monosaccharide Transport Proteins; Neutrophils; Nitric Oxide Synthase; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Stroke | 2000 |
Prothrombotic markers in atrial fibrillation: what is new?
Topics: Atrial Fibrillation; Biomarkers; Chronic Disease; Fibrinogen; Humans; P-Selectin; Stroke; von Willebrand Factor | 2001 |
Haemorheological, endothelial and platelet function in subjects with hypertension: relationship to cardiovascular risk and influence of antihypertensive treatment.
Topics: Antihypertensive Agents; Biomarkers; Blood Viscosity; Coronary Disease; Cross-Sectional Studies; Female; Fibrinogen; Hematocrit; Hemorheology; Humans; Hypertension; Male; P-Selectin; Risk Factors; Stroke; von Willebrand Factor | 2001 |
[Fibrinogen: a cardiovascular risk factor].
Topics: Adult; Aged; Aortic Diseases; Arteriosclerosis; Cardiovascular Diseases; Coronary Angiography; Coronary Disease; Female; Fibrinogen; Humans; Leg; Life Style; Male; Pregnancy; Prospective Studies; Risk; Risk Factors; Smoking; Stroke | 2000 |
Mutation in the promoter region of the beta-fibrinogen gene and the risk of future myocardial infarction, stroke and venous thrombosis.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Cohort Studies; Coronary Artery Disease; DNA Primers; Fibrinogen; Genotype; Germany; Humans; Male; Massachusetts; Middle Aged; Mutation; Myocardial Infarction; Polymerase Chain Reaction; Polymorphism, Genetic; Promoter Regions, Genetic; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Smoking; Stroke; Venous Thrombosis; White People | 2001 |
Haemostasis in ischaemic stroke and vascular dementia.
Topics: Acute-Phase Reaction; Aged; Brain Ischemia; Case-Control Studies; Dementia, Vascular; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Stroke; von Willebrand Factor | 2001 |
[beta-fibrinogen gene -455A/G polymorphism and plasma fibrinogen level in Chinese stroke patients].
Topics: Adult; Aged; Asian People; Brain Ischemia; Female; Fibrinogen; Gene Frequency; Humans; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Stroke | 2000 |
Level of fibrinogen and risk of fatal and non-fatal stroke. EUROSTROKE: a collaborative study among research centres in Europe.
Topics: Adult; Aged; Biomarkers; Case-Control Studies; Databases, Factual; Europe; Female; Fibrinogen; Humans; Male; Middle Aged; Multicenter Studies as Topic; Risk; Stroke | 2002 |
Prediction of stroke in the general population in Europe (EUROSTROKE): Is there a role for fibrinogen and electrocardiography?
Topics: Adult; Age Factors; Aged; Case-Control Studies; Databases, Factual; Electrocardiography; Europe; Female; Fibrinogen; Humans; Logistic Models; Male; Middle Aged; Multicenter Studies as Topic; Predictive Value of Tests; Recurrence; Risk Factors; Stroke | 2002 |
[Fibrinogen and monocyte count during the initial phase of ischaemic ictus].
Topics: Aged; Brain Ischemia; Female; Fibrinogen; Humans; Leukocyte Count; Male; Monocytes; Stroke | 2002 |
Spontaneous echo-contrast as an in vivo indicator of rheological imbalance in dilatative cardiomyopathy.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Blood Viscosity; Cardiomyopathy, Dilated; Cardiovascular Agents; Echocardiography, Transesophageal; Erythrocytes; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heart Atria; Hematocrit; Hemorheology; Humans; Male; Middle Aged; Partial Thromboplastin Time; Prothrombin Time; Risk Factors; Stroke; Stroke Volume | 2001 |
beta-fibrinogen gene -455A/G polymorphism and plasma fibrinogen level in Chinese stroke patients.
Topics: Aged; Alleles; Brain Ischemia; China; DNA; Female; Fibrinogen; Gene Frequency; Genotype; Humans; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Single-Stranded Conformational; Stroke | 2002 |
Effects of cholesterol and inflammation-sensitive plasma proteins on incidence of myocardial infarction and stroke in men.
Topics: Adult; alpha 1-Antitrypsin; Biomarkers; Blood Proteins; Ceruloplasmin; Cholesterol; Cohort Studies; Comorbidity; Fibrinogen; Follow-Up Studies; Haptoglobins; Humans; Hypercholesterolemia; Incidence; Inflammation; Male; Middle Aged; Mortality; Myocardial Infarction; Orosomucoid; Risk Factors; Stroke; Sweden | 2002 |
Increased fibrinogen, von Willebrand factor and tissue plasminogen activator levels in insulin resistant South Asian patients with ischaemic stroke.
Topics: Asia, Southeastern; Coronary Thrombosis; Female; Fibrinogen; Hemostasis; Humans; Insulin Resistance; Male; Middle Aged; Random Allocation; Risk Factors; Stroke; Tissue Plasminogen Activator; von Willebrand Factor | 2002 |
Lp(a), homocysteine and a family history of early ischemic cerebral stroke.
Topics: Adolescent; Adult; Brain Ischemia; Factor VII; Female; Fibrinogen; Genetic Predisposition to Disease; Homocysteine; Humans; Lipoprotein(a); Male; Middle Aged; Regression Analysis; Risk Factors; Severity of Illness Index; Stroke; Uric Acid | 2001 |
Blood coagulation and fibrinolysis in acute ischaemic and haemorrhagic (intracerebral and subarachnoid haemorrhage) stroke: does decreased plasmin inhibitor indicate increased fibrinolysis in subarachnoid haemorrhage compared to other types of stroke?
Topics: Acute Disease; Adult; Aged; Antifibrinolytic Agents; Blood Coagulation; Brain Ischemia; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Stroke; Subarachnoid Hemorrhage | 2002 |
Inflammation, hemostatic markers, and antithrombotic agents in relation to long-term risk of new cardiovascular events in first-ever ischemic stroke patients.
Topics: Aged; Anticoagulants; Biomarkers; Brain; Brain Ischemia; C-Reactive Protein; Cardiovascular Diseases; Comorbidity; Disease-Free Survival; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolytic Agents; Humans; Inflammation; Magnetic Resonance Imaging; Male; Multivariate Analysis; Platelet Aggregation Inhibitors; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Recurrence; Risk Assessment; Stroke; Time; Tomography, X-Ray Computed; Treatment Outcome | 2002 |